Unacceptable principal diagnosis - ICD-10-CM Medicare Code Edits
There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.
The following 2,478 ICD-10-CM codes are intended for unacceptable principal diagnosis
| ICD Code | Description | Category |
|---|---|---|
| B95.0 | Streptococcus, group A, as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.1 | Streptococcus, group B, as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.2 | Enterococcus as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.3 | Streptococcus pneumoniae as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.4 | Other streptococcus as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.5 | Unspecified streptococcus as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.61 | Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.62 | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.7 | Other staphylococcus as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B95.8 | Unspecified staphylococcus as the cause of diseases classified elsewhere | Strep as the cause of diseases classified elsewhere (B95) |
| B96.0 | Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.1 | Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.20 | Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.21 | Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.22 | Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.23 | Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.29 | Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.3 | Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.4 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.6 | Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.7 | Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.81 | Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.82 | Vibrio vulnificus as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B96.89 | Other specified bacterial agents as the cause of diseases classified elsewhere | Oth bacterial agents as the cause of diseases classd elswhr (B96) |
| B97.0 | Adenovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.10 | Unspecified enterovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.11 | Coxsackievirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.12 | Echovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.19 | Other enterovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.21 | SARS-associated coronavirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.29 | Other coronavirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.30 | Unspecified retrovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.31 | Lentivirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.32 | Oncovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.33 | Human T-cell lymphotrophic virus, type I [HTLV-I] as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.34 | Human T-cell lymphotrophic virus, type II [HTLV-II] as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.39 | Other retrovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.4 | Respiratory syncytial virus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.5 | Reovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.6 | Parvovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.7 | Papillomavirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.81 | Human metapneumovirus as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| B97.89 | Other viral agents as the cause of diseases classified elsewhere | Viral agents as the cause of diseases classified elsewhere (B97) |
| C80.2 | Malignant neoplasm associated with transplanted organ | Malignant neoplasm without specification of site (C80) |
| D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) | Oth neoplm of uncrt behav of lymphoid, hematpoetc & rel tiss (D47) |
| D89.810 | Acute graft-versus-host disease | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.811 | Chronic graft-versus-host disease | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.812 | Acute on chronic graft-versus-host disease | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.813 | Graft-versus-host disease, unspecified | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.831 | Cytokine release syndrome, grade 1 | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.832 | Cytokine release syndrome, grade 2 | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.833 | Cytokine release syndrome, grade 3 | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.834 | Cytokine release syndrome, grade 4 | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.835 | Cytokine release syndrome, grade 5 | Oth disorders involving the immune mechanism, NEC (D89) |
| D89.839 | Cytokine release syndrome, grade unspecified | Oth disorders involving the immune mechanism, NEC (D89) |
| F07.89 | Other personality and behavioral disorders due to known physiological condition | Personality & behavrl disorders due to known physiol cond (F07) |
| F17.200 | Nicotine dependence, unspecified, uncomplicated | Nicotine dependence (F17) |
| F17.201 | Nicotine dependence, unspecified, in remission | Nicotine dependence (F17) |
| F17.210 | Nicotine dependence, cigarettes, uncomplicated | Nicotine dependence (F17) |
| F17.211 | Nicotine dependence, cigarettes, in remission | Nicotine dependence (F17) |
| F17.220 | Nicotine dependence, chewing tobacco, uncomplicated | Nicotine dependence (F17) |
| F17.221 | Nicotine dependence, chewing tobacco, in remission | Nicotine dependence (F17) |
| F17.290 | Nicotine dependence, other tobacco product, uncomplicated | Nicotine dependence (F17) |
| F17.291 | Nicotine dependence, other tobacco product, in remission | Nicotine dependence (F17) |
| F52.9 | Unspecified sexual dysfunction not due to a substance or known physiological condition | Sexual dysfnct not due to a substance or known physiol cond (F52) |
| F81.9 | Developmental disorder of scholastic skills, unspecified | Specific developmental disorders of scholastic skills (F81) |
| G73.1 | Lambert-Eaton syndrome in neoplastic disease | Disord of myoneural junction and muscle in dis classd elswhr (G73) |
| G92.00 | Immune effector cell-associated neurotoxicity syndrome, grade unspecified | Toxic encephalopathy (G92) |
| G92.01 | Immune effector cell-associated neurotoxicity syndrome, grade 1 | Toxic encephalopathy (G92) |
| G92.02 | Immune effector cell-associated neurotoxicity syndrome, grade 2 | Toxic encephalopathy (G92) |
| G92.03 | Immune effector cell-associated neurotoxicity syndrome, grade 3 | Toxic encephalopathy (G92) |
| G92.04 | Immune effector cell-associated neurotoxicity syndrome, grade 4 | Toxic encephalopathy (G92) |
| G92.05 | Immune effector cell-associated neurotoxicity syndrome, grade 5 | Toxic encephalopathy (G92) |
| H16.8 | Other keratitis | Keratitis (H16) |
| H40.1210 | Low-tension glaucoma, right eye, stage unspecified | Glaucoma (H40) |
| H40.1211 | Low-tension glaucoma, right eye, mild stage | Glaucoma (H40) |
| H40.1212 | Low-tension glaucoma, right eye, moderate stage | Glaucoma (H40) |
| H40.1213 | Low-tension glaucoma, right eye, severe stage | Glaucoma (H40) |
| H40.1214 | Low-tension glaucoma, right eye, indeterminate stage | Glaucoma (H40) |
| H40.1220 | Low-tension glaucoma, left eye, stage unspecified | Glaucoma (H40) |
| H40.1221 | Low-tension glaucoma, left eye, mild stage | Glaucoma (H40) |
| H40.1222 | Low-tension glaucoma, left eye, moderate stage | Glaucoma (H40) |
| H40.1223 | Low-tension glaucoma, left eye, severe stage | Glaucoma (H40) |
| H40.1224 | Low-tension glaucoma, left eye, indeterminate stage | Glaucoma (H40) |
| H40.1230 | Low-tension glaucoma, bilateral, stage unspecified | Glaucoma (H40) |
| H40.1231 | Low-tension glaucoma, bilateral, mild stage | Glaucoma (H40) |
| H40.1232 | Low-tension glaucoma, bilateral, moderate stage | Glaucoma (H40) |
| H40.1233 | Low-tension glaucoma, bilateral, severe stage | Glaucoma (H40) |
| H40.1234 | Low-tension glaucoma, bilateral, indeterminate stage | Glaucoma (H40) |
| H40.1290 | Low-tension glaucoma, unspecified eye, stage unspecified | Glaucoma (H40) |
| H40.1291 | Low-tension glaucoma, unspecified eye, mild stage | Glaucoma (H40) |
| H40.1292 | Low-tension glaucoma, unspecified eye, moderate stage | Glaucoma (H40) |
| H40.1293 | Low-tension glaucoma, unspecified eye, severe stage | Glaucoma (H40) |
| H40.1294 | Low-tension glaucoma, unspecified eye, indeterminate stage | Glaucoma (H40) |
| H40.1310 | Pigmentary glaucoma, right eye, stage unspecified | Glaucoma (H40) |
| H40.1311 | Pigmentary glaucoma, right eye, mild stage | Glaucoma (H40) |
| H40.1312 | Pigmentary glaucoma, right eye, moderate stage | Glaucoma (H40) |
| H40.1313 | Pigmentary glaucoma, right eye, severe stage | Glaucoma (H40) |
| H40.1314 | Pigmentary glaucoma, right eye, indeterminate stage | Glaucoma (H40) |
| H40.1320 | Pigmentary glaucoma, left eye, stage unspecified | Glaucoma (H40) |
| H40.1321 | Pigmentary glaucoma, left eye, mild stage | Glaucoma (H40) |
| H40.1322 | Pigmentary glaucoma, left eye, moderate stage | Glaucoma (H40) |
| H40.1323 | Pigmentary glaucoma, left eye, severe stage | Glaucoma (H40) |
| H40.1324 | Pigmentary glaucoma, left eye, indeterminate stage | Glaucoma (H40) |
| H40.1330 | Pigmentary glaucoma, bilateral, stage unspecified | Glaucoma (H40) |
| H40.1331 | Pigmentary glaucoma, bilateral, mild stage | Glaucoma (H40) |
| H40.1332 | Pigmentary glaucoma, bilateral, moderate stage | Glaucoma (H40) |
| H40.1333 | Pigmentary glaucoma, bilateral, severe stage | Glaucoma (H40) |
| H40.1334 | Pigmentary glaucoma, bilateral, indeterminate stage | Glaucoma (H40) |
| H40.1390 | Pigmentary glaucoma, unspecified eye, stage unspecified | Glaucoma (H40) |
| H40.1391 | Pigmentary glaucoma, unspecified eye, mild stage | Glaucoma (H40) |
| H40.1392 | Pigmentary glaucoma, unspecified eye, moderate stage | Glaucoma (H40) |
| H40.1393 | Pigmentary glaucoma, unspecified eye, severe stage | Glaucoma (H40) |
| H40.1394 | Pigmentary glaucoma, unspecified eye, indeterminate stage | Glaucoma (H40) |
| H40.151 | Residual stage of open-angle glaucoma, right eye | Glaucoma (H40) |
| H40.152 | Residual stage of open-angle glaucoma, left eye | Glaucoma (H40) |
| H40.153 | Residual stage of open-angle glaucoma, bilateral | Glaucoma (H40) |
| H40.159 | Residual stage of open-angle glaucoma, unspecified eye | Glaucoma (H40) |
| H54.7 | Unspecified visual loss | Blindness and low vision (H54) |
| H57.9 | Unspecified disorder of eye and adnexa | Other disorders of eye and adnexa (H57) |
| H93.90 | Unspecified disorder of ear, unspecified ear | Other disorders of ear, not elsewhere classified (H93) |
| H93.91 | Unspecified disorder of right ear | Other disorders of ear, not elsewhere classified (H93) |
| H93.92 | Unspecified disorder of left ear | Other disorders of ear, not elsewhere classified (H93) |
| H93.93 | Unspecified disorder of ear, bilateral | Other disorders of ear, not elsewhere classified (H93) |
| I25.82 | Chronic total occlusion of coronary artery | Chronic ischemic heart disease (I25) |
| I25.83 | Coronary atherosclerosis due to lipid rich plaque | Chronic ischemic heart disease (I25) |
| I25.84 | Coronary atherosclerosis due to calcified coronary lesion | Chronic ischemic heart disease (I25) |
| I26.01 | Septic pulmonary embolism with acute cor pulmonale | Pulmonary embolism (I26) |
| I26.90 | Septic pulmonary embolism without acute cor pulmonale | Pulmonary embolism (I26) |
| I31.4 | Cardiac tamponade | Other diseases of pericardium (I31) |
| I46.2 | Cardiac arrest due to underlying cardiac condition | Cardiac arrest (I46) |
| I46.8 | Cardiac arrest due to other underlying condition | Cardiac arrest (I46) |
| I70.92 | Chronic total occlusion of artery of the extremities | Atherosclerosis (I70) |
| I76 | Septic arterial embolism | Septic arterial embolism (I76) |
| J12.82 | Pneumonia due to coronavirus disease 2019 | Viral pneumonia, not elsewhere classified (J12) |
| J93.12 | Secondary spontaneous pneumothorax | Pneumothorax and air leak (J93) |
| K74.00 | Hepatic fibrosis, unspecified | Fibrosis and cirrhosis of liver (K74) |
| K74.01 | Hepatic fibrosis, early fibrosis | Fibrosis and cirrhosis of liver (K74) |
| K74.02 | Hepatic fibrosis, advanced fibrosis | Fibrosis and cirrhosis of liver (K74) |
| K76.81 | Hepatopulmonary syndrome | Other diseases of liver (K76) |
| L49.0 | Exfoliation due to erythematous condition involving less than 10 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.1 | Exfoliation due to erythematous condition involving 10-19 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.2 | Exfoliation due to erythematous condition involving 20-29 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.3 | Exfoliation due to erythematous condition involving 30-39 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.4 | Exfoliation due to erythematous condition involving 40-49 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.5 | Exfoliation due to erythematous condition involving 50-59 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.6 | Exfoliation due to erythematous condition involving 60-69 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.7 | Exfoliation due to erythematous condition involving 70-79 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.8 | Exfoliation due to erythematous condition involving 80-89 percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| L49.9 | Exfoliation due to erythematous condition involving 90 or more percent of body surface | Exfoliatn due to erythemat cond accord extent body involv (L49) |
| M40.10 | Other secondary kyphosis, site unspecified | Kyphosis and lordosis (M40) |
| M40.12 | Other secondary kyphosis, cervical region | Kyphosis and lordosis (M40) |
| M40.13 | Other secondary kyphosis, cervicothoracic region | Kyphosis and lordosis (M40) |
| M40.14 | Other secondary kyphosis, thoracic region | Kyphosis and lordosis (M40) |
| M40.15 | Other secondary kyphosis, thoracolumbar region | Kyphosis and lordosis (M40) |
| M41.50 | Other secondary scoliosis, site unspecified | Scoliosis (M41) |
| M41.52 | Other secondary scoliosis, cervical region | Scoliosis (M41) |
| M41.53 | Other secondary scoliosis, cervicothoracic region | Scoliosis (M41) |
| M41.54 | Other secondary scoliosis, thoracic region | Scoliosis (M41) |
| M41.55 | Other secondary scoliosis, thoracolumbar region | Scoliosis (M41) |
| M41.56 | Other secondary scoliosis, lumbar region | Scoliosis (M41) |
| M41.57 | Other secondary scoliosis, lumbosacral region | Scoliosis (M41) |
| N64.1 | Fat necrosis of breast | Other disorders of breast (N64) |
| O09.00 | Supervision of pregnancy with history of infertility, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.01 | Supervision of pregnancy with history of infertility, first trimester | Supervision of high risk pregnancy (O09) |
| O09.02 | Supervision of pregnancy with history of infertility, second trimester | Supervision of high risk pregnancy (O09) |
| O09.03 | Supervision of pregnancy with history of infertility, third trimester | Supervision of high risk pregnancy (O09) |
| O09.10 | Supervision of pregnancy with history of ectopic pregnancy, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.11 | Supervision of pregnancy with history of ectopic pregnancy, first trimester | Supervision of high risk pregnancy (O09) |
| O09.12 | Supervision of pregnancy with history of ectopic pregnancy, second trimester | Supervision of high risk pregnancy (O09) |
| O09.13 | Supervision of pregnancy with history of ectopic pregnancy, third trimester | Supervision of high risk pregnancy (O09) |
| O09.211 | Supervision of pregnancy with history of pre-term labor, first trimester | Supervision of high risk pregnancy (O09) |
| O09.212 | Supervision of pregnancy with history of pre-term labor, second trimester | Supervision of high risk pregnancy (O09) |
| O09.213 | Supervision of pregnancy with history of pre-term labor, third trimester | Supervision of high risk pregnancy (O09) |
| O09.219 | Supervision of pregnancy with history of pre-term labor, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.291 | Supervision of pregnancy with other poor reproductive or obstetric history, first trimester | Supervision of high risk pregnancy (O09) |
| O09.292 | Supervision of pregnancy with other poor reproductive or obstetric history, second trimester | Supervision of high risk pregnancy (O09) |
| O09.293 | Supervision of pregnancy with other poor reproductive or obstetric history, third trimester | Supervision of high risk pregnancy (O09) |
| O09.299 | Supervision of pregnancy with other poor reproductive or obstetric history, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.30 | Supervision of pregnancy with insufficient antenatal care, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.31 | Supervision of pregnancy with insufficient antenatal care, first trimester | Supervision of high risk pregnancy (O09) |
| O09.32 | Supervision of pregnancy with insufficient antenatal care, second trimester | Supervision of high risk pregnancy (O09) |
| O09.33 | Supervision of pregnancy with insufficient antenatal care, third trimester | Supervision of high risk pregnancy (O09) |
| O09.40 | Supervision of pregnancy with grand multiparity, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.41 | Supervision of pregnancy with grand multiparity, first trimester | Supervision of high risk pregnancy (O09) |
| O09.42 | Supervision of pregnancy with grand multiparity, second trimester | Supervision of high risk pregnancy (O09) |
| O09.43 | Supervision of pregnancy with grand multiparity, third trimester | Supervision of high risk pregnancy (O09) |
| O09.511 | Supervision of elderly primigravida, first trimester | Supervision of high risk pregnancy (O09) |
| O09.512 | Supervision of elderly primigravida, second trimester | Supervision of high risk pregnancy (O09) |
| O09.513 | Supervision of elderly primigravida, third trimester | Supervision of high risk pregnancy (O09) |
| O09.519 | Supervision of elderly primigravida, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.521 | Supervision of elderly multigravida, first trimester | Supervision of high risk pregnancy (O09) |
| O09.522 | Supervision of elderly multigravida, second trimester | Supervision of high risk pregnancy (O09) |
| O09.523 | Supervision of elderly multigravida, third trimester | Supervision of high risk pregnancy (O09) |
| O09.529 | Supervision of elderly multigravida, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.611 | Supervision of young primigravida, first trimester | Supervision of high risk pregnancy (O09) |
| O09.612 | Supervision of young primigravida, second trimester | Supervision of high risk pregnancy (O09) |
| O09.613 | Supervision of young primigravida, third trimester | Supervision of high risk pregnancy (O09) |
| O09.619 | Supervision of young primigravida, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.621 | Supervision of young multigravida, first trimester | Supervision of high risk pregnancy (O09) |
| O09.622 | Supervision of young multigravida, second trimester | Supervision of high risk pregnancy (O09) |
| O09.623 | Supervision of young multigravida, third trimester | Supervision of high risk pregnancy (O09) |
| O09.629 | Supervision of young multigravida, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.70 | Supervision of high risk pregnancy due to social problems, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.71 | Supervision of high risk pregnancy due to social problems, first trimester | Supervision of high risk pregnancy (O09) |
| O09.72 | Supervision of high risk pregnancy due to social problems, second trimester | Supervision of high risk pregnancy (O09) |
| O09.73 | Supervision of high risk pregnancy due to social problems, third trimester | Supervision of high risk pregnancy (O09) |
| O09.811 | Supervision of pregnancy resulting from assisted reproductive technology, first trimester | Supervision of high risk pregnancy (O09) |
| O09.812 | Supervision of pregnancy resulting from assisted reproductive technology, second trimester | Supervision of high risk pregnancy (O09) |
| O09.813 | Supervision of pregnancy resulting from assisted reproductive technology, third trimester | Supervision of high risk pregnancy (O09) |
| O09.819 | Supervision of pregnancy resulting from assisted reproductive technology, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.821 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, first trimester | Supervision of high risk pregnancy (O09) |
| O09.822 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, second trimester | Supervision of high risk pregnancy (O09) |
| O09.823 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, third trimester | Supervision of high risk pregnancy (O09) |
| O09.829 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.891 | Supervision of other high risk pregnancies, first trimester | Supervision of high risk pregnancy (O09) |
| O09.892 | Supervision of other high risk pregnancies, second trimester | Supervision of high risk pregnancy (O09) |
| O09.893 | Supervision of other high risk pregnancies, third trimester | Supervision of high risk pregnancy (O09) |
| O09.899 | Supervision of other high risk pregnancies, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.90 | Supervision of high risk pregnancy, unspecified, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.91 | Supervision of high risk pregnancy, unspecified, first trimester | Supervision of high risk pregnancy (O09) |
| O09.92 | Supervision of high risk pregnancy, unspecified, second trimester | Supervision of high risk pregnancy (O09) |
| O09.93 | Supervision of high risk pregnancy, unspecified, third trimester | Supervision of high risk pregnancy (O09) |
| O09.A0 | Supervision of pregnancy with history of molar pregnancy, unspecified trimester | Supervision of high risk pregnancy (O09) |
| O09.A1 | Supervision of pregnancy with history of molar pregnancy, first trimester | Supervision of high risk pregnancy (O09) |
| O09.A2 | Supervision of pregnancy with history of molar pregnancy, second trimester | Supervision of high risk pregnancy (O09) |
| O09.A3 | Supervision of pregnancy with history of molar pregnancy, third trimester | Supervision of high risk pregnancy (O09) |
| O36.80X0 | Pregnancy with inconclusive fetal viability, not applicable or unspecified | Maternal care for other fetal problems (O36) |
| O36.80X1 | Pregnancy with inconclusive fetal viability, fetus 1 | Maternal care for other fetal problems (O36) |
| O36.80X2 | Pregnancy with inconclusive fetal viability, fetus 2 | Maternal care for other fetal problems (O36) |
| O36.80X3 | Pregnancy with inconclusive fetal viability, fetus 3 | Maternal care for other fetal problems (O36) |
| O36.80X4 | Pregnancy with inconclusive fetal viability, fetus 4 | Maternal care for other fetal problems (O36) |
| O36.80X5 | Pregnancy with inconclusive fetal viability, fetus 5 | Maternal care for other fetal problems (O36) |
| O36.80X9 | Pregnancy with inconclusive fetal viability, other fetus | Maternal care for other fetal problems (O36) |
| O94 | Sequelae of complication of pregnancy, childbirth, and the puerperium | Sequelae of comp of pregnancy, chldbrth, and the puerperium (O94) |
| O99.820 | Streptococcus B carrier state complicating pregnancy | Oth maternal diseases classd elsw but compl preg/chldbrth (O99) |
| O99.825 | Streptococcus B carrier state complicating the puerperium | Oth maternal diseases classd elsw but compl preg/chldbrth (O99) |
| R05.4 | Cough syncope | Cough (R05) |
| R18.0 | Malignant ascites | Ascites (R18) |
| R29.700 | NIHSS score 0 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.701 | NIHSS score 1 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.702 | NIHSS score 2 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.703 | NIHSS score 3 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.704 | NIHSS score 4 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.705 | NIHSS score 5 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.706 | NIHSS score 6 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.707 | NIHSS score 7 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.708 | NIHSS score 8 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.709 | NIHSS score 9 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.710 | NIHSS score 10 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.711 | NIHSS score 11 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.712 | NIHSS score 12 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.713 | NIHSS score 13 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.714 | NIHSS score 14 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.715 | NIHSS score 15 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.716 | NIHSS score 16 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.717 | NIHSS score 17 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.718 | NIHSS score 18 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.719 | NIHSS score 19 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.720 | NIHSS score 20 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.721 | NIHSS score 21 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.722 | NIHSS score 22 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.723 | NIHSS score 23 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.724 | NIHSS score 24 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.725 | NIHSS score 25 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.726 | NIHSS score 26 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.727 | NIHSS score 27 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.728 | NIHSS score 28 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.729 | NIHSS score 29 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.730 | NIHSS score 30 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.731 | NIHSS score 31 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.732 | NIHSS score 32 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.733 | NIHSS score 33 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.734 | NIHSS score 34 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.735 | NIHSS score 35 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.736 | NIHSS score 36 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.737 | NIHSS score 37 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.738 | NIHSS score 38 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.739 | NIHSS score 39 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.740 | NIHSS score 40 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.741 | NIHSS score 41 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R29.742 | NIHSS score 42 | Oth symptoms and signs involving the nervous and ms systems (R29) |
| R40.2110 | Coma scale, eyes open, never, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2111 | Coma scale, eyes open, never, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2112 | Coma scale, eyes open, never, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2113 | Coma scale, eyes open, never, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2114 | Coma scale, eyes open, never, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2120 | Coma scale, eyes open, to pain, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2121 | Coma scale, eyes open, to pain, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2122 | Coma scale, eyes open, to pain, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2123 | Coma scale, eyes open, to pain, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2124 | Coma scale, eyes open, to pain, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2130 | Coma scale, eyes open, to sound, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2131 | Coma scale, eyes open, to sound, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2132 | Coma scale, eyes open, to sound, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2133 | Coma scale, eyes open, to sound, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2134 | Coma scale, eyes open, to sound, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2140 | Coma scale, eyes open, spontaneous, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2141 | Coma scale, eyes open, spontaneous, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2142 | Coma scale, eyes open, spontaneous, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2143 | Coma scale, eyes open, spontaneous, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2144 | Coma scale, eyes open, spontaneous, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2210 | Coma scale, best verbal response, none, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2211 | Coma scale, best verbal response, none, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2212 | Coma scale, best verbal response, none, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2213 | Coma scale, best verbal response, none, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2214 | Coma scale, best verbal response, none, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2220 | Coma scale, best verbal response, incomprehensible words, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2221 | Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2222 | Coma scale, best verbal response, incomprehensible words, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2223 | Coma scale, best verbal response, incomprehensible words, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2224 | Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2230 | Coma scale, best verbal response, inappropriate words, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2231 | Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2232 | Coma scale, best verbal response, inappropriate words, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2233 | Coma scale, best verbal response, inappropriate words, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2234 | Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2240 | Coma scale, best verbal response, confused conversation, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2241 | Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2242 | Coma scale, best verbal response, confused conversation, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2243 | Coma scale, best verbal response, confused conversation, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2244 | Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2250 | Coma scale, best verbal response, oriented, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2251 | Coma scale, best verbal response, oriented, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2252 | Coma scale, best verbal response, oriented, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2253 | Coma scale, best verbal response, oriented, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2254 | Coma scale, best verbal response, oriented, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2310 | Coma scale, best motor response, none, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2311 | Coma scale, best motor response, none, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2312 | Coma scale, best motor response, none, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2313 | Coma scale, best motor response, none, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2314 | Coma scale, best motor response, none, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2320 | Coma scale, best motor response, extension, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2321 | Coma scale, best motor response, extension, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2322 | Coma scale, best motor response, extension, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2323 | Coma scale, best motor response, extension, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2324 | Coma scale, best motor response, extension, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2330 | Coma scale, best motor response, abnormal flexion, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2331 | Coma scale, best motor response, abnormal flexion, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2332 | Coma scale, best motor response, abnormal flexion, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2333 | Coma scale, best motor response, abnormal flexion, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2334 | Coma scale, best motor response, abnormal flexion, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2340 | Coma scale, best motor response, flexion withdrawal, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2341 | Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2342 | Coma scale, best motor response, flexion withdrawal, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2343 | Coma scale, best motor response, flexion withdrawal, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2344 | Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2350 | Coma scale, best motor response, localizes pain, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2351 | Coma scale, best motor response, localizes pain, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2352 | Coma scale, best motor response, localizes pain, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2353 | Coma scale, best motor response, localizes pain, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2354 | Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2360 | Coma scale, best motor response, obeys commands, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2361 | Coma scale, best motor response, obeys commands, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2362 | Coma scale, best motor response, obeys commands, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2363 | Coma scale, best motor response, obeys commands, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2364 | Coma scale, best motor response, obeys commands, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2410 | Glasgow coma scale score 13-15, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2411 | Glasgow coma scale score 13-15, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2412 | Glasgow coma scale score 13-15, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2413 | Glasgow coma scale score 13-15, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2414 | Glasgow coma scale score 13-15, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2420 | Glasgow coma scale score 9-12, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2421 | Glasgow coma scale score 9-12, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2422 | Glasgow coma scale score 9-12, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2423 | Glasgow coma scale score 9-12, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2424 | Glasgow coma scale score 9-12, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2430 | Glasgow coma scale score 3-8, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2431 | Glasgow coma scale score 3-8, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2432 | Glasgow coma scale score 3-8, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2433 | Glasgow coma scale score 3-8, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2434 | Glasgow coma scale score 3-8, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R40.2440 | Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time | Somnolence, stupor and coma (R40) |
| R40.2441 | Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance] | Somnolence, stupor and coma (R40) |
| R40.2442 | Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department | Somnolence, stupor and coma (R40) |
| R40.2443 | Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission | Somnolence, stupor and coma (R40) |
| R40.2444 | Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission | Somnolence, stupor and coma (R40) |
| R41.83 | Borderline intellectual functioning | Oth symptoms and signs w cognitive functions and awareness (R41) |
| R45.850 | Homicidal ideations | Symptoms and signs involving emotional state (R45) |
| R46.81 | Obsessive-compulsive behavior | Symptoms and signs involving appearance and behavior (R46) |
| R46.89 | Other symptoms and signs involving appearance and behavior | Symptoms and signs involving appearance and behavior (R46) |
| R65.10 | Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction | Symp and signs specifically assoc w sys inflam and infct (R65) |
| R65.11 | Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction | Symp and signs specifically assoc w sys inflam and infct (R65) |
| R65.20 | Severe sepsis without septic shock | Symp and signs specifically assoc w sys inflam and infct (R65) |
| R65.21 | Severe sepsis with septic shock | Symp and signs specifically assoc w sys inflam and infct (R65) |
| S06.A0XA | Traumatic brain compression without herniation, initial encounter | Intracranial injury (S06) |
| S06.A0XD | Traumatic brain compression without herniation, subsequent encounter | Intracranial injury (S06) |
| S06.A0XS | Traumatic brain compression without herniation, sequela | Intracranial injury (S06) |
| S06.A1XA | Traumatic brain compression with herniation, initial encounter | Intracranial injury (S06) |
| S06.A1XD | Traumatic brain compression with herniation, subsequent encounter | Intracranial injury (S06) |
| S06.A1XS | Traumatic brain compression with herniation, sequela | Intracranial injury (S06) |
| T36.0X5A | Adverse effect of penicillins, initial encounter | Systemic antibiotics (T36) |
| T36.0X5D | Adverse effect of penicillins, subsequent encounter | Systemic antibiotics (T36) |
| T36.0X5S | Adverse effect of penicillins, sequela | Systemic antibiotics (T36) |
| T36.0X6A | Underdosing of penicillins, initial encounter | Systemic antibiotics (T36) |
| T36.0X6D | Underdosing of penicillins, subsequent encounter | Systemic antibiotics (T36) |
| T36.0X6S | Underdosing of penicillins, sequela | Systemic antibiotics (T36) |
| T36.1X5A | Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter | Systemic antibiotics (T36) |
| T36.1X5D | Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter | Systemic antibiotics (T36) |
| T36.1X5S | Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela | Systemic antibiotics (T36) |
| T36.1X6A | Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter | Systemic antibiotics (T36) |
| T36.1X6D | Underdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter | Systemic antibiotics (T36) |
| T36.1X6S | Underdosing of cephalosporins and other beta-lactam antibiotics, sequela | Systemic antibiotics (T36) |
| T36.2X5A | Adverse effect of chloramphenicol group, initial encounter | Systemic antibiotics (T36) |
| T36.2X5D | Adverse effect of chloramphenicol group, subsequent encounter | Systemic antibiotics (T36) |
| T36.2X5S | Adverse effect of chloramphenicol group, sequela | Systemic antibiotics (T36) |
| T36.2X6A | Underdosing of chloramphenicol group, initial encounter | Systemic antibiotics (T36) |
| T36.2X6D | Underdosing of chloramphenicol group, subsequent encounter | Systemic antibiotics (T36) |
| T36.2X6S | Underdosing of chloramphenicol group, sequela | Systemic antibiotics (T36) |
| T36.3X5A | Adverse effect of macrolides, initial encounter | Systemic antibiotics (T36) |
| T36.3X5D | Adverse effect of macrolides, subsequent encounter | Systemic antibiotics (T36) |
| T36.3X5S | Adverse effect of macrolides, sequela | Systemic antibiotics (T36) |
| T36.3X6A | Underdosing of macrolides, initial encounter | Systemic antibiotics (T36) |
| T36.3X6D | Underdosing of macrolides, subsequent encounter | Systemic antibiotics (T36) |
| T36.3X6S | Underdosing of macrolides, sequela | Systemic antibiotics (T36) |
| T36.4X5A | Adverse effect of tetracyclines, initial encounter | Systemic antibiotics (T36) |
| T36.4X5D | Adverse effect of tetracyclines, subsequent encounter | Systemic antibiotics (T36) |
| T36.4X5S | Adverse effect of tetracyclines, sequela | Systemic antibiotics (T36) |
| T36.4X6A | Underdosing of tetracyclines, initial encounter | Systemic antibiotics (T36) |
| T36.4X6D | Underdosing of tetracyclines, subsequent encounter | Systemic antibiotics (T36) |
| T36.4X6S | Underdosing of tetracyclines, sequela | Systemic antibiotics (T36) |
| T36.5X5A | Adverse effect of aminoglycosides, initial encounter | Systemic antibiotics (T36) |
| T36.5X5D | Adverse effect of aminoglycosides, subsequent encounter | Systemic antibiotics (T36) |
| T36.5X5S | Adverse effect of aminoglycosides, sequela | Systemic antibiotics (T36) |
| T36.5X6A | Underdosing of aminoglycosides, initial encounter | Systemic antibiotics (T36) |
| T36.5X6D | Underdosing of aminoglycosides, subsequent encounter | Systemic antibiotics (T36) |
| T36.5X6S | Underdosing of aminoglycosides, sequela | Systemic antibiotics (T36) |
| T36.6X5A | Adverse effect of rifampicins, initial encounter | Systemic antibiotics (T36) |
| T36.6X5D | Adverse effect of rifampicins, subsequent encounter | Systemic antibiotics (T36) |
| T36.6X5S | Adverse effect of rifampicins, sequela | Systemic antibiotics (T36) |
| T36.6X6A | Underdosing of rifampicins, initial encounter | Systemic antibiotics (T36) |
| T36.6X6D | Underdosing of rifampicins, subsequent encounter | Systemic antibiotics (T36) |
| T36.6X6S | Underdosing of rifampicins, sequela | Systemic antibiotics (T36) |
| T36.7X5A | Adverse effect of antifungal antibiotics, systemically used, initial encounter | Systemic antibiotics (T36) |
| T36.7X5D | Adverse effect of antifungal antibiotics, systemically used, subsequent encounter | Systemic antibiotics (T36) |
| T36.7X5S | Adverse effect of antifungal antibiotics, systemically used, sequela | Systemic antibiotics (T36) |
| T36.7X6A | Underdosing of antifungal antibiotics, systemically used, initial encounter | Systemic antibiotics (T36) |
| T36.7X6D | Underdosing of antifungal antibiotics, systemically used, subsequent encounter | Systemic antibiotics (T36) |
| T36.7X6S | Underdosing of antifungal antibiotics, systemically used, sequela | Systemic antibiotics (T36) |
| T36.8X5A | Adverse effect of other systemic antibiotics, initial encounter | Systemic antibiotics (T36) |
| T36.8X5D | Adverse effect of other systemic antibiotics, subsequent encounter | Systemic antibiotics (T36) |
| T36.8X5S | Adverse effect of other systemic antibiotics, sequela | Systemic antibiotics (T36) |
| T36.8X6A | Underdosing of other systemic antibiotics, initial encounter | Systemic antibiotics (T36) |
| T36.8X6D | Underdosing of other systemic antibiotics, subsequent encounter | Systemic antibiotics (T36) |
| T36.8X6S | Underdosing of other systemic antibiotics, sequela | Systemic antibiotics (T36) |
| T36.95XA | Adverse effect of unspecified systemic antibiotic, initial encounter | Systemic antibiotics (T36) |
| T36.95XD | Adverse effect of unspecified systemic antibiotic, subsequent encounter | Systemic antibiotics (T36) |
| T36.95XS | Adverse effect of unspecified systemic antibiotic, sequela | Systemic antibiotics (T36) |
| T36.96XA | Underdosing of unspecified systemic antibiotic, initial encounter | Systemic antibiotics (T36) |
| T36.96XD | Underdosing of unspecified systemic antibiotic, subsequent encounter | Systemic antibiotics (T36) |
| T36.96XS | Underdosing of unspecified systemic antibiotic, sequela | Systemic antibiotics (T36) |
| T37.0X5A | Adverse effect of sulfonamides, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.0X5D | Adverse effect of sulfonamides, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.0X5S | Adverse effect of sulfonamides, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.0X6A | Underdosing of sulfonamides, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.0X6D | Underdosing of sulfonamides, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.0X6S | Underdosing of sulfonamides, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.1X5A | Adverse effect of antimycobacterial drugs, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.1X5D | Adverse effect of antimycobacterial drugs, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.1X5S | Adverse effect of antimycobacterial drugs, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.1X6A | Underdosing of antimycobacterial drugs, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.1X6D | Underdosing of antimycobacterial drugs, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.1X6S | Underdosing of antimycobacterial drugs, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.2X5A | Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.2X5D | Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.2X5S | Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.2X6A | Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.2X6D | Underdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.2X6S | Underdosing of antimalarials and drugs acting on other blood protozoa, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.3X5A | Adverse effect of other antiprotozoal drugs, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.3X5D | Adverse effect of other antiprotozoal drugs, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.3X5S | Adverse effect of other antiprotozoal drugs, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.3X6A | Underdosing of other antiprotozoal drugs, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.3X6D | Underdosing of other antiprotozoal drugs, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.3X6S | Underdosing of other antiprotozoal drugs, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.4X5A | Adverse effect of anthelminthics, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.4X5D | Adverse effect of anthelminthics, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.4X5S | Adverse effect of anthelminthics, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.4X6A | Underdosing of anthelminthics, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.4X6D | Underdosing of anthelminthics, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.4X6S | Underdosing of anthelminthics, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.5X5A | Adverse effect of antiviral drugs, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.5X5D | Adverse effect of antiviral drugs, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.5X5S | Adverse effect of antiviral drugs, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.5X6A | Underdosing of antiviral drugs, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.5X6D | Underdosing of antiviral drugs, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.5X6S | Underdosing of antiviral drugs, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.8X5A | Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.8X5D | Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.8X5S | Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.8X6A | Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.8X6D | Underdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.8X6S | Underdosing of other specified systemic anti-infectives and antiparasitics, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.95XA | Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.95XD | Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.95XS | Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T37.96XA | Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.96XD | Underdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounter | Other systemic anti-infectives and antiparasitics (T37) |
| T37.96XS | Underdosing of unspecified systemic anti-infectives and antiparasitics, sequela | Other systemic anti-infectives and antiparasitics (T37) |
| T38.0X5A | Adverse effect of glucocorticoids and synthetic analogues, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.0X5D | Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.0X5S | Adverse effect of glucocorticoids and synthetic analogues, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.0X6A | Underdosing of glucocorticoids and synthetic analogues, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.0X6D | Underdosing of glucocorticoids and synthetic analogues, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.0X6S | Underdosing of glucocorticoids and synthetic analogues, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.1X5A | Adverse effect of thyroid hormones and substitutes, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.1X5D | Adverse effect of thyroid hormones and substitutes, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.1X5S | Adverse effect of thyroid hormones and substitutes, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.1X6A | Underdosing of thyroid hormones and substitutes, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.1X6D | Underdosing of thyroid hormones and substitutes, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.1X6S | Underdosing of thyroid hormones and substitutes, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.2X5A | Adverse effect of antithyroid drugs, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.2X5D | Adverse effect of antithyroid drugs, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.2X5S | Adverse effect of antithyroid drugs, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.2X6A | Underdosing of antithyroid drugs, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.2X6D | Underdosing of antithyroid drugs, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.2X6S | Underdosing of antithyroid drugs, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.3X5A | Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.3X5D | Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.3X5S | Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.3X6A | Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.3X6D | Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.3X6S | Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.4X5A | Adverse effect of oral contraceptives, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.4X5D | Adverse effect of oral contraceptives, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.4X5S | Adverse effect of oral contraceptives, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.4X6A | Underdosing of oral contraceptives, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.4X6D | Underdosing of oral contraceptives, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.4X6S | Underdosing of oral contraceptives, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.5X5A | Adverse effect of other estrogens and progestogens, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.5X5D | Adverse effect of other estrogens and progestogens, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.5X5S | Adverse effect of other estrogens and progestogens, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.5X6A | Underdosing of other estrogens and progestogens, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.5X6D | Underdosing of other estrogens and progestogens, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.5X6S | Underdosing of other estrogens and progestogens, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.6X5A | Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.6X5D | Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.6X5S | Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.6X6A | Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.6X6D | Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.6X6S | Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.7X5A | Adverse effect of androgens and anabolic congeners, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.7X5D | Adverse effect of androgens and anabolic congeners, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.7X5S | Adverse effect of androgens and anabolic congeners, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.7X6A | Underdosing of androgens and anabolic congeners, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.7X6D | Underdosing of androgens and anabolic congeners, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.7X6S | Underdosing of androgens and anabolic congeners, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.805A | Adverse effect of unspecified hormones and synthetic substitutes, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.805D | Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.805S | Adverse effect of unspecified hormones and synthetic substitutes, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.806A | Underdosing of unspecified hormones and synthetic substitutes, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.806D | Underdosing of unspecified hormones and synthetic substitutes, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.806S | Underdosing of unspecified hormones and synthetic substitutes, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.815A | Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.815D | Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.815S | Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.816A | Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.816D | Underdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.816S | Underdosing of anterior pituitary [adenohypophyseal] hormones, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.895A | Adverse effect of other hormones and synthetic substitutes, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.895D | Adverse effect of other hormones and synthetic substitutes, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.895S | Adverse effect of other hormones and synthetic substitutes, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.896A | Underdosing of other hormones and synthetic substitutes, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.896D | Underdosing of other hormones and synthetic substitutes, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.896S | Underdosing of other hormones and synthetic substitutes, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.905A | Adverse effect of unspecified hormone antagonists, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.905D | Adverse effect of unspecified hormone antagonists, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.905S | Adverse effect of unspecified hormone antagonists, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.906A | Underdosing of unspecified hormone antagonists, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.906D | Underdosing of unspecified hormone antagonists, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.906S | Underdosing of unspecified hormone antagonists, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.995A | Adverse effect of other hormone antagonists, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.995D | Adverse effect of other hormone antagonists, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.995S | Adverse effect of other hormone antagonists, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.996A | Underdosing of other hormone antagonists, initial encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.996D | Underdosing of other hormone antagonists, subsequent encounter | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T38.996S | Underdosing of other hormone antagonists, sequela | Hormones and their synthetic substitutes and antag, NEC (T38) |
| T39.015A | Adverse effect of aspirin, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.015D | Adverse effect of aspirin, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.015S | Adverse effect of aspirin, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.016A | Underdosing of aspirin, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.016D | Underdosing of aspirin, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.016S | Underdosing of aspirin, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.095A | Adverse effect of salicylates, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.095D | Adverse effect of salicylates, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.095S | Adverse effect of salicylates, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.096A | Underdosing of salicylates, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.096D | Underdosing of salicylates, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.096S | Underdosing of salicylates, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.1X5A | Adverse effect of 4-Aminophenol derivatives, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.1X5D | Adverse effect of 4-Aminophenol derivatives, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.1X5S | Adverse effect of 4-Aminophenol derivatives, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.1X6A | Underdosing of 4-Aminophenol derivatives, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.1X6D | Underdosing of 4-Aminophenol derivatives, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.1X6S | Underdosing of 4-Aminophenol derivatives, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.2X5A | Adverse effect of pyrazolone derivatives, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.2X5D | Adverse effect of pyrazolone derivatives, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.2X5S | Adverse effect of pyrazolone derivatives, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.2X6A | Underdosing of pyrazolone derivatives, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.2X6D | Underdosing of pyrazolone derivatives, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.2X6S | Underdosing of pyrazolone derivatives, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.315A | Adverse effect of propionic acid derivatives, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.315D | Adverse effect of propionic acid derivatives, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.315S | Adverse effect of propionic acid derivatives, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.316A | Underdosing of propionic acid derivatives, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.316D | Underdosing of propionic acid derivatives, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.316S | Underdosing of propionic acid derivatives, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.395A | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.395D | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.395S | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.396A | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.396D | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.396S | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.4X5A | Adverse effect of antirheumatics, not elsewhere classified, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.4X5D | Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.4X5S | Adverse effect of antirheumatics, not elsewhere classified, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.4X6A | Underdosing of antirheumatics, not elsewhere classified, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.4X6D | Underdosing of antirheumatics, not elsewhere classified, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.4X6S | Underdosing of antirheumatics, not elsewhere classified, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.8X5A | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.8X5D | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.8X5S | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.8X6A | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.8X6D | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.8X6S | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.95XA | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.95XD | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.95XS | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.96XA | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.96XD | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T39.96XS | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela | Nonopioid analgesics, antipyretics and antirheumatics (T39) |
| T40.0X5A | Adverse effect of opium, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.0X5D | Adverse effect of opium, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.0X5S | Adverse effect of opium, sequela | Narcotics and psychodysleptics (T40) |
| T40.0X6A | Underdosing of opium, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.0X6D | Underdosing of opium, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.0X6S | Underdosing of opium, sequela | Narcotics and psychodysleptics (T40) |
| T40.2X5A | Adverse effect of other opioids, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.2X5D | Adverse effect of other opioids, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.2X5S | Adverse effect of other opioids, sequela | Narcotics and psychodysleptics (T40) |
| T40.2X6A | Underdosing of other opioids, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.2X6D | Underdosing of other opioids, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.2X6S | Underdosing of other opioids, sequela | Narcotics and psychodysleptics (T40) |
| T40.3X5A | Adverse effect of methadone, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.3X5D | Adverse effect of methadone, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.3X5S | Adverse effect of methadone, sequela | Narcotics and psychodysleptics (T40) |
| T40.3X6A | Underdosing of methadone, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.3X6D | Underdosing of methadone, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.3X6S | Underdosing of methadone, sequela | Narcotics and psychodysleptics (T40) |
| T40.415A | Adverse effect of fentanyl or fentanyl analogs, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.415D | Adverse effect of fentanyl or fentanyl analogs, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.415S | Adverse effect of fentanyl or fentanyl analogs, sequela | Narcotics and psychodysleptics (T40) |
| T40.416A | Underdosing of fentanyl or fentanyl analogs, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.416D | Underdosing of fentanyl or fentanyl analogs, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.416S | Underdosing of fentanyl or fentanyl analogs, sequela | Narcotics and psychodysleptics (T40) |
| T40.425A | Adverse effect of tramadol, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.425D | Adverse effect of tramadol, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.425S | Adverse effect of tramadol, sequela | Narcotics and psychodysleptics (T40) |
| T40.426A | Underdosing of tramadol, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.426D | Underdosing of tramadol, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.426S | Underdosing of tramadol, sequela | Narcotics and psychodysleptics (T40) |
| T40.495A | Adverse effect of other synthetic narcotics, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.495D | Adverse effect of other synthetic narcotics, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.495S | Adverse effect of other synthetic narcotics, sequela | Narcotics and psychodysleptics (T40) |
| T40.496A | Underdosing of other synthetic narcotics, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.496D | Underdosing of other synthetic narcotics, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.496S | Underdosing of other synthetic narcotics, sequela | Narcotics and psychodysleptics (T40) |
| T40.5X5A | Adverse effect of cocaine, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.5X5D | Adverse effect of cocaine, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.5X5S | Adverse effect of cocaine, sequela | Narcotics and psychodysleptics (T40) |
| T40.5X6A | Underdosing of cocaine, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.5X6D | Underdosing of cocaine, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.5X6S | Underdosing of cocaine, sequela | Narcotics and psychodysleptics (T40) |
| T40.605A | Adverse effect of unspecified narcotics, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.605D | Adverse effect of unspecified narcotics, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.605S | Adverse effect of unspecified narcotics, sequela | Narcotics and psychodysleptics (T40) |
| T40.606A | Underdosing of unspecified narcotics, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.606D | Underdosing of unspecified narcotics, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.606S | Underdosing of unspecified narcotics, sequela | Narcotics and psychodysleptics (T40) |
| T40.695A | Adverse effect of other narcotics, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.695D | Adverse effect of other narcotics, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.695S | Adverse effect of other narcotics, sequela | Narcotics and psychodysleptics (T40) |
| T40.696A | Underdosing of other narcotics, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.696D | Underdosing of other narcotics, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.696S | Underdosing of other narcotics, sequela | Narcotics and psychodysleptics (T40) |
| T40.715A | Adverse effect of cannabis, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.715D | Adverse effect of cannabis, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.715S | Adverse effect of cannabis, sequela | Narcotics and psychodysleptics (T40) |
| T40.716A | Underdosing of cannabis, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.716D | Underdosing of cannabis, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.716S | Underdosing of cannabis, sequela | Narcotics and psychodysleptics (T40) |
| T40.725A | Adverse effect of synthetic cannabinoids, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.725D | Adverse effect of synthetic cannabinoids, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.725S | Adverse effect of synthetic cannabinoids, sequela | Narcotics and psychodysleptics (T40) |
| T40.726A | Underdosing of synthetic cannabinoids, initial encounter | Narcotics and psychodysleptics (T40) |
| T40.726D | Underdosing of synthetic cannabinoids, subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.726S | Underdosing of synthetic cannabinoids, sequela | Narcotics and psychodysleptics (T40) |
| T40.905A | Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter | Narcotics and psychodysleptics (T40) |
| T40.905D | Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.905S | Adverse effect of unspecified psychodysleptics [hallucinogens], sequela | Narcotics and psychodysleptics (T40) |
| T40.906A | Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter | Narcotics and psychodysleptics (T40) |
| T40.906D | Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.906S | Underdosing of unspecified psychodysleptics [hallucinogens], sequela | Narcotics and psychodysleptics (T40) |
| T40.995A | Adverse effect of other psychodysleptics [hallucinogens], initial encounter | Narcotics and psychodysleptics (T40) |
| T40.995D | Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.995S | Adverse effect of other psychodysleptics [hallucinogens], sequela | Narcotics and psychodysleptics (T40) |
| T40.996A | Underdosing of other psychodysleptics [hallucinogens], initial encounter | Narcotics and psychodysleptics (T40) |
| T40.996D | Underdosing of other psychodysleptics [hallucinogens], subsequent encounter | Narcotics and psychodysleptics (T40) |
| T40.996S | Underdosing of other psychodysleptics [hallucinogens], sequela | Narcotics and psychodysleptics (T40) |
| T41.0X5A | Adverse effect of inhaled anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.0X5D | Adverse effect of inhaled anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.0X5S | Adverse effect of inhaled anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.0X6A | Underdosing of inhaled anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.0X6D | Underdosing of inhaled anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.0X6S | Underdosing of inhaled anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.1X5A | Adverse effect of intravenous anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.1X5D | Adverse effect of intravenous anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.1X5S | Adverse effect of intravenous anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.1X6A | Underdosing of intravenous anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.1X6D | Underdosing of intravenous anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.1X6S | Underdosing of intravenous anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.205A | Adverse effect of unspecified general anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.205D | Adverse effect of unspecified general anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.205S | Adverse effect of unspecified general anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.206A | Underdosing of unspecified general anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.206D | Underdosing of unspecified general anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.206S | Underdosing of unspecified general anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.295A | Adverse effect of other general anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.295D | Adverse effect of other general anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.295S | Adverse effect of other general anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.296A | Underdosing of other general anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.296D | Underdosing of other general anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.296S | Underdosing of other general anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.3X5A | Adverse effect of local anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.3X5D | Adverse effect of local anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.3X5S | Adverse effect of local anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.3X6A | Underdosing of local anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.3X6D | Underdosing of local anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.3X6S | Underdosing of local anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.45XA | Adverse effect of unspecified anesthetic, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.45XD | Adverse effect of unspecified anesthetic, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.45XS | Adverse effect of unspecified anesthetic, sequela | Anesthetics and therapeutic gases (T41) |
| T41.46XA | Underdosing of unspecified anesthetics, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.46XD | Underdosing of unspecified anesthetics, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.46XS | Underdosing of unspecified anesthetics, sequela | Anesthetics and therapeutic gases (T41) |
| T41.5X5A | Adverse effect of therapeutic gases, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.5X5D | Adverse effect of therapeutic gases, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.5X5S | Adverse effect of therapeutic gases, sequela | Anesthetics and therapeutic gases (T41) |
| T41.5X6A | Underdosing of therapeutic gases, initial encounter | Anesthetics and therapeutic gases (T41) |
| T41.5X6D | Underdosing of therapeutic gases, subsequent encounter | Anesthetics and therapeutic gases (T41) |
| T41.5X6S | Underdosing of therapeutic gases, sequela | Anesthetics and therapeutic gases (T41) |
| T42.0X5A | Adverse effect of hydantoin derivatives, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.0X5D | Adverse effect of hydantoin derivatives, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.0X5S | Adverse effect of hydantoin derivatives, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.0X6A | Underdosing of hydantoin derivatives, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.0X6D | Underdosing of hydantoin derivatives, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.0X6S | Underdosing of hydantoin derivatives, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.1X5A | Adverse effect of iminostilbenes, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.1X5D | Adverse effect of iminostilbenes, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.1X5S | Adverse effect of iminostilbenes, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.1X6A | Underdosing of iminostilbenes, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.1X6D | Underdosing of iminostilbenes, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.1X6S | Underdosing of iminostilbenes, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.2X5A | Adverse effect of succinimides and oxazolidinediones, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.2X5D | Adverse effect of succinimides and oxazolidinediones, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.2X5S | Adverse effect of succinimides and oxazolidinediones, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.2X6A | Underdosing of succinimides and oxazolidinediones, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.2X6D | Underdosing of succinimides and oxazolidinediones, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.2X6S | Underdosing of succinimides and oxazolidinediones, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.3X5A | Adverse effect of barbiturates, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.3X5D | Adverse effect of barbiturates, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.3X5S | Adverse effect of barbiturates, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.3X6A | Underdosing of barbiturates, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.3X6D | Underdosing of barbiturates, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.3X6S | Underdosing of barbiturates, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.4X5A | Adverse effect of benzodiazepines, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.4X5D | Adverse effect of benzodiazepines, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.4X5S | Adverse effect of benzodiazepines, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.4X6A | Underdosing of benzodiazepines, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.4X6D | Underdosing of benzodiazepines, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.4X6S | Underdosing of benzodiazepines, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.5X5A | Adverse effect of mixed antiepileptics, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.5X5D | Adverse effect of mixed antiepileptics, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.5X5S | Adverse effect of mixed antiepileptics, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.5X6A | Underdosing of mixed antiepileptics, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.5X6D | Underdosing of mixed antiepileptics, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.5X6S | Underdosing of mixed antiepileptics, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.6X5A | Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.6X5D | Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.6X5S | Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.6X6A | Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.6X6D | Underdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.6X6S | Underdosing of other antiepileptic and sedative-hypnotic drugs, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.75XA | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.75XD | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.75XS | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.76XA | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.76XD | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.76XS | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.8X5A | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.8X5D | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.8X5S | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.8X6A | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.8X6D | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T42.8X6S | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela | Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42) |
| T43.015A | Adverse effect of tricyclic antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.015D | Adverse effect of tricyclic antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.015S | Adverse effect of tricyclic antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.016A | Underdosing of tricyclic antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.016D | Underdosing of tricyclic antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.016S | Underdosing of tricyclic antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.025A | Adverse effect of tetracyclic antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.025D | Adverse effect of tetracyclic antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.025S | Adverse effect of tetracyclic antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.026A | Underdosing of tetracyclic antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.026D | Underdosing of tetracyclic antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.026S | Underdosing of tetracyclic antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.1X5A | Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.1X5D | Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.1X5S | Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.1X6A | Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.1X6D | Underdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.1X6S | Underdosing of monoamine-oxidase-inhibitor antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.205A | Adverse effect of unspecified antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.205D | Adverse effect of unspecified antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.205S | Adverse effect of unspecified antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.206A | Underdosing of unspecified antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.206D | Underdosing of unspecified antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.206S | Underdosing of unspecified antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.215A | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.215D | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.215S | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.216A | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.216D | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.216S | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.225A | Adverse effect of selective serotonin reuptake inhibitors, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.225D | Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.225S | Adverse effect of selective serotonin reuptake inhibitors, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.226A | Underdosing of selective serotonin reuptake inhibitors, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.226D | Underdosing of selective serotonin reuptake inhibitors, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.226S | Underdosing of selective serotonin reuptake inhibitors, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.295A | Adverse effect of other antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.295D | Adverse effect of other antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.295S | Adverse effect of other antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.296A | Underdosing of other antidepressants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.296D | Underdosing of other antidepressants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.296S | Underdosing of other antidepressants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.3X5A | Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.3X5D | Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.3X5S | Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.3X6A | Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.3X6D | Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.3X6S | Underdosing of phenothiazine antipsychotics and neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.4X5A | Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.4X5D | Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.4X5S | Adverse effect of butyrophenone and thiothixene neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.4X6A | Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.4X6D | Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.4X6S | Underdosing of butyrophenone and thiothixene neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.505A | Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.505D | Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.505S | Adverse effect of unspecified antipsychotics and neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.506A | Underdosing of unspecified antipsychotics and neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.506D | Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.506S | Underdosing of unspecified antipsychotics and neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.595A | Adverse effect of other antipsychotics and neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.595D | Adverse effect of other antipsychotics and neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.595S | Adverse effect of other antipsychotics and neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.596A | Underdosing of other antipsychotics and neuroleptics, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.596D | Underdosing of other antipsychotics and neuroleptics, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.596S | Underdosing of other antipsychotics and neuroleptics, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.605A | Adverse effect of unspecified psychostimulants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.605D | Adverse effect of unspecified psychostimulants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.605S | Adverse effect of unspecified psychostimulants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.606A | Underdosing of unspecified psychostimulants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.606D | Underdosing of unspecified psychostimulants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.606S | Underdosing of unspecified psychostimulants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.615A | Adverse effect of caffeine, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.615D | Adverse effect of caffeine, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.615S | Adverse effect of caffeine, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.616A | Underdosing of caffeine, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.616D | Underdosing of caffeine, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.616S | Underdosing of caffeine, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.625A | Adverse effect of amphetamines, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.625D | Adverse effect of amphetamines, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.625S | Adverse effect of amphetamines, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.626A | Underdosing of amphetamines, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.626D | Underdosing of amphetamines, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.626S | Underdosing of amphetamines, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.635A | Adverse effect of methylphenidate, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.635D | Adverse effect of methylphenidate, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.635S | Adverse effect of methylphenidate, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.636A | Underdosing of methylphenidate, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.636D | Underdosing of methylphenidate, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.636S | Underdosing of methylphenidate, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.695A | Adverse effect of other psychostimulants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.695D | Adverse effect of other psychostimulants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.695S | Adverse effect of other psychostimulants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.696A | Underdosing of other psychostimulants, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.696D | Underdosing of other psychostimulants, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.696S | Underdosing of other psychostimulants, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.8X5A | Adverse effect of other psychotropic drugs, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.8X5D | Adverse effect of other psychotropic drugs, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.8X5S | Adverse effect of other psychotropic drugs, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.8X6A | Underdosing of other psychotropic drugs, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.8X6D | Underdosing of other psychotropic drugs, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.8X6S | Underdosing of other psychotropic drugs, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.95XA | Adverse effect of unspecified psychotropic drug, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.95XD | Adverse effect of unspecified psychotropic drug, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.95XS | Adverse effect of unspecified psychotropic drug, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T43.96XA | Underdosing of unspecified psychotropic drug, initial encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.96XD | Underdosing of unspecified psychotropic drug, subsequent encounter | Psychotropic drugs, not elsewhere classified (T43) |
| T43.96XS | Underdosing of unspecified psychotropic drug, sequela | Psychotropic drugs, not elsewhere classified (T43) |
| T44.0X5A | Adverse effect of anticholinesterase agents, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.0X5D | Adverse effect of anticholinesterase agents, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.0X5S | Adverse effect of anticholinesterase agents, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.0X6A | Underdosing of anticholinesterase agents, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.0X6D | Underdosing of anticholinesterase agents, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.0X6S | Underdosing of anticholinesterase agents, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.1X5A | Adverse effect of other parasympathomimetics [cholinergics], initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.1X5D | Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.1X5S | Adverse effect of other parasympathomimetics [cholinergics], sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.1X6A | Underdosing of other parasympathomimetics [cholinergics], initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.1X6D | Underdosing of other parasympathomimetics [cholinergics], subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.1X6S | Underdosing of other parasympathomimetics [cholinergics], sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.2X5A | Adverse effect of ganglionic blocking drugs, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.2X5D | Adverse effect of ganglionic blocking drugs, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.2X5S | Adverse effect of ganglionic blocking drugs, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.2X6A | Underdosing of ganglionic blocking drugs, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.2X6D | Underdosing of ganglionic blocking drugs, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.2X6S | Underdosing of ganglionic blocking drugs, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.3X5A | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.3X5D | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.3X5S | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.3X6A | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.3X6D | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.3X6S | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.4X5A | Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.4X5D | Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.4X5S | Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.4X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.4X6D | Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.4X6S | Underdosing of predominantly alpha-adrenoreceptor agonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.5X5A | Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.5X5D | Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.5X5S | Adverse effect of predominantly beta-adrenoreceptor agonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.5X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.5X6D | Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.5X6S | Underdosing of predominantly beta-adrenoreceptor agonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.6X5A | Adverse effect of alpha-adrenoreceptor antagonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.6X5D | Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.6X5S | Adverse effect of alpha-adrenoreceptor antagonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.6X6A | Underdosing of alpha-adrenoreceptor antagonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.6X6D | Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.6X6S | Underdosing of alpha-adrenoreceptor antagonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.7X5A | Adverse effect of beta-adrenoreceptor antagonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.7X5D | Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.7X5S | Adverse effect of beta-adrenoreceptor antagonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.7X6A | Underdosing of beta-adrenoreceptor antagonists, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.7X6D | Underdosing of beta-adrenoreceptor antagonists, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.7X6S | Underdosing of beta-adrenoreceptor antagonists, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.8X5A | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.8X5D | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.8X5S | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.8X6A | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.8X6D | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.8X6S | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.905A | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.905D | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.905S | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.906A | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.906D | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.906S | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.995A | Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.995D | Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.995S | Adverse effect of other drug primarily affecting the autonomic nervous system, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.996A | Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.996D | Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter | Drugs primarily affecting the autonomic nervous system (T44) |
| T44.996S | Underdosing of other drug primarily affecting the autonomic nervous system, sequela | Drugs primarily affecting the autonomic nervous system (T44) |
| T45.0X5A | Adverse effect of antiallergic and antiemetic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.0X5D | Adverse effect of antiallergic and antiemetic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.0X5S | Adverse effect of antiallergic and antiemetic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.0X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.0X6D | Underdosing of antiallergic and antiemetic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.0X6S | Underdosing of antiallergic and antiemetic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.1X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.1X5D | Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.1X5S | Adverse effect of antineoplastic and immunosuppressive drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.1X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.1X6D | Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.1X6S | Underdosing of antineoplastic and immunosuppressive drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.2X5A | Adverse effect of vitamins, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.2X5D | Adverse effect of vitamins, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.2X5S | Adverse effect of vitamins, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.2X6A | Underdosing of vitamins, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.2X6D | Underdosing of vitamins, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.2X6S | Underdosing of vitamins, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.3X5A | Adverse effect of enzymes, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.3X5D | Adverse effect of enzymes, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.3X5S | Adverse effect of enzymes, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.3X6A | Underdosing of enzymes, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.3X6D | Underdosing of enzymes, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.3X6S | Underdosing of enzymes, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.4X5A | Adverse effect of iron and its compounds, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.4X5D | Adverse effect of iron and its compounds, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.4X5S | Adverse effect of iron and its compounds, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.4X6A | Underdosing of iron and its compounds, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.4X6D | Underdosing of iron and its compounds, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.4X6S | Underdosing of iron and its compounds, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.515A | Adverse effect of anticoagulants, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.515D | Adverse effect of anticoagulants, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.515S | Adverse effect of anticoagulants, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.516A | Underdosing of anticoagulants, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.516D | Underdosing of anticoagulants, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.516S | Underdosing of anticoagulants, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.525A | Adverse effect of antithrombotic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.525D | Adverse effect of antithrombotic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.525S | Adverse effect of antithrombotic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.526A | Underdosing of antithrombotic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.526D | Underdosing of antithrombotic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.526S | Underdosing of antithrombotic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.605A | Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.605D | Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.605S | Adverse effect of unspecified fibrinolysis-affecting drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.606D | Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.606S | Underdosing of unspecified fibrinolysis-affecting drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.615A | Adverse effect of thrombolytic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.615D | Adverse effect of thrombolytic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.615S | Adverse effect of thrombolytic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.616A | Underdosing of thrombolytic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.616D | Underdosing of thrombolytic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.616S | Underdosing of thrombolytic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.625A | Adverse effect of hemostatic drug, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.625D | Adverse effect of hemostatic drug, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.625S | Adverse effect of hemostatic drug, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.626A | Underdosing of hemostatic drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.626D | Underdosing of hemostatic drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.626S | Underdosing of hemostatic drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.695A | Adverse effect of other fibrinolysis-affecting drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.695D | Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.695S | Adverse effect of other fibrinolysis-affecting drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.696D | Underdosing of other fibrinolysis-affecting drugs, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.696S | Underdosing of other fibrinolysis-affecting drugs, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.7X5A | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.7X5D | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.7X5S | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.7X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.7X6D | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.7X6S | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.8X5A | Adverse effect of other primarily systemic and hematological agents, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.8X5D | Adverse effect of other primarily systemic and hematological agents, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.8X5S | Adverse effect of other primarily systemic and hematological agents, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.8X6A | Underdosing of other primarily systemic and hematological agents, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.8X6D | Underdosing of other primarily systemic and hematological agents, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.8X6S | Underdosing of other primarily systemic and hematological agents, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.95XA | Adverse effect of unspecified primarily systemic and hematological agent, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.95XD | Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.95XS | Adverse effect of unspecified primarily systemic and hematological agent, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T45.96XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.96XD | Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter | Primarily systemic and hematological agents, NEC (T45) |
| T45.96XS | Underdosing of unspecified primarily systemic and hematological agent, sequela | Primarily systemic and hematological agents, NEC (T45) |
| T46.0X5A | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.0X5D | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.0X5S | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.0X6A | Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.0X6D | Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.0X6S | Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.1X5A | Adverse effect of calcium-channel blockers, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.1X5D | Adverse effect of calcium-channel blockers, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.1X5S | Adverse effect of calcium-channel blockers, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.1X6A | Underdosing of calcium-channel blockers, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.1X6D | Underdosing of calcium-channel blockers, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.1X6S | Underdosing of calcium-channel blockers, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.2X5A | Adverse effect of other antidysrhythmic drugs, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.2X5D | Adverse effect of other antidysrhythmic drugs, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.2X5S | Adverse effect of other antidysrhythmic drugs, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.2X6A | Underdosing of other antidysrhythmic drugs, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.2X6D | Underdosing of other antidysrhythmic drugs, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.2X6S | Underdosing of other antidysrhythmic drugs, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.3X5A | Adverse effect of coronary vasodilators, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.3X5D | Adverse effect of coronary vasodilators, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.3X5S | Adverse effect of coronary vasodilators, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.3X6A | Underdosing of coronary vasodilators, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.3X6D | Underdosing of coronary vasodilators, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.3X6S | Underdosing of coronary vasodilators, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.4X5A | Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.4X5D | Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.4X5S | Adverse effect of angiotensin-converting-enzyme inhibitors, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.4X6A | Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.4X6D | Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.4X6S | Underdosing of angiotensin-converting-enzyme inhibitors, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.5X5A | Adverse effect of other antihypertensive drugs, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.5X5D | Adverse effect of other antihypertensive drugs, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.5X5S | Adverse effect of other antihypertensive drugs, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.5X6A | Underdosing of other antihypertensive drugs, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.5X6D | Underdosing of other antihypertensive drugs, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.5X6S | Underdosing of other antihypertensive drugs, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.6X5A | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.6X5D | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.6X5S | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.6X6A | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.6X6D | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.6X6S | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.7X5A | Adverse effect of peripheral vasodilators, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.7X5D | Adverse effect of peripheral vasodilators, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.7X5S | Adverse effect of peripheral vasodilators, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.7X6A | Underdosing of peripheral vasodilators, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.7X6D | Underdosing of peripheral vasodilators, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.7X6S | Underdosing of peripheral vasodilators, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.8X5A | Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.8X5D | Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.8X5S | Adverse effect of antivaricose drugs, including sclerosing agents, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.8X6A | Underdosing of antivaricose drugs, including sclerosing agents, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.8X6D | Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.8X6S | Underdosing of antivaricose drugs, including sclerosing agents, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.905A | Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.905D | Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.905S | Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.906A | Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.906D | Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.906S | Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.995A | Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.995D | Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.995S | Adverse effect of other agents primarily affecting the cardiovascular system, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T46.996A | Underdosing of other agents primarily affecting the cardiovascular system, initial encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.996D | Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter | Agents primarily affecting the cardiovascular system (T46) |
| T46.996S | Underdosing of other agents primarily affecting the cardiovascular system, sequela | Agents primarily affecting the cardiovascular system (T46) |
| T47.0X5A | Adverse effect of histamine H2-receptor blockers, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.0X5D | Adverse effect of histamine H2-receptor blockers, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.0X5S | Adverse effect of histamine H2-receptor blockers, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.0X6A | Underdosing of histamine H2-receptor blockers, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.0X6D | Underdosing of histamine H2-receptor blockers, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.0X6S | Underdosing of histamine H2-receptor blockers, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.1X5A | Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.1X5D | Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.1X5S | Adverse effect of other antacids and anti-gastric-secretion drugs, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.1X6A | Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.1X6D | Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.1X6S | Underdosing of other antacids and anti-gastric-secretion drugs, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.2X5A | Adverse effect of stimulant laxatives, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.2X5D | Adverse effect of stimulant laxatives, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.2X5S | Adverse effect of stimulant laxatives, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.2X6A | Underdosing of stimulant laxatives, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.2X6D | Underdosing of stimulant laxatives, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.2X6S | Underdosing of stimulant laxatives, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.3X5A | Adverse effect of saline and osmotic laxatives, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.3X5D | Adverse effect of saline and osmotic laxatives, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.3X5S | Adverse effect of saline and osmotic laxatives, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.3X6A | Underdosing of saline and osmotic laxatives, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.3X6D | Underdosing of saline and osmotic laxatives, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.3X6S | Underdosing of saline and osmotic laxatives, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.4X5A | Adverse effect of other laxatives, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.4X5D | Adverse effect of other laxatives, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.4X5S | Adverse effect of other laxatives, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.4X6A | Underdosing of other laxatives, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.4X6D | Underdosing of other laxatives, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.4X6S | Underdosing of other laxatives, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.5X5A | Adverse effect of digestants, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.5X5D | Adverse effect of digestants, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.5X5S | Adverse effect of digestants, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.5X6A | Underdosing of digestants, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.5X6D | Underdosing of digestants, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.5X6S | Underdosing of digestants, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.6X5A | Adverse effect of antidiarrheal drugs, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.6X5D | Adverse effect of antidiarrheal drugs, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.6X5S | Adverse effect of antidiarrheal drugs, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.6X6A | Underdosing of antidiarrheal drugs, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.6X6D | Underdosing of antidiarrheal drugs, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.6X6S | Underdosing of antidiarrheal drugs, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.7X5A | Adverse effect of emetics, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.7X5D | Adverse effect of emetics, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.7X5S | Adverse effect of emetics, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.7X6A | Underdosing of emetics, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.7X6D | Underdosing of emetics, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.7X6S | Underdosing of emetics, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.8X5A | Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.8X5D | Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.8X5S | Adverse effect of other agents primarily affecting gastrointestinal system, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.8X6A | Underdosing of other agents primarily affecting gastrointestinal system, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.8X6D | Underdosing of other agents primarily affecting gastrointestinal system, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.8X6S | Underdosing of other agents primarily affecting gastrointestinal system, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.95XA | Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.95XD | Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.95XS | Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T47.96XA | Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.96XD | Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter | Agents primarily affecting the gastrointestinal system (T47) |
| T47.96XS | Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela | Agents primarily affecting the gastrointestinal system (T47) |
| T48.0X5A | Adverse effect of oxytocic drugs, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.0X5D | Adverse effect of oxytocic drugs, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.0X5S | Adverse effect of oxytocic drugs, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.0X6A | Underdosing of oxytocic drugs, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.0X6D | Underdosing of oxytocic drugs, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.0X6S | Underdosing of oxytocic drugs, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.1X5A | Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.1X5D | Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.1X5S | Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.1X6A | Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.1X6D | Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.1X6S | Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.205A | Adverse effect of unspecified drugs acting on muscles, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.205D | Adverse effect of unspecified drugs acting on muscles, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.205S | Adverse effect of unspecified drugs acting on muscles, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.206A | Underdosing of unspecified drugs acting on muscles, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.206D | Underdosing of unspecified drugs acting on muscles, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.206S | Underdosing of unspecified drugs acting on muscles, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.295A | Adverse effect of other drugs acting on muscles, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.295D | Adverse effect of other drugs acting on muscles, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.295S | Adverse effect of other drugs acting on muscles, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.296A | Underdosing of other drugs acting on muscles, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.296D | Underdosing of other drugs acting on muscles, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.296S | Underdosing of other drugs acting on muscles, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.3X5A | Adverse effect of antitussives, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.3X5D | Adverse effect of antitussives, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.3X5S | Adverse effect of antitussives, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.3X6A | Underdosing of antitussives, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.3X6D | Underdosing of antitussives, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.3X6S | Underdosing of antitussives, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.4X5A | Adverse effect of expectorants, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.4X5D | Adverse effect of expectorants, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.4X5S | Adverse effect of expectorants, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.4X6A | Underdosing of expectorants, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.4X6D | Underdosing of expectorants, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.4X6S | Underdosing of expectorants, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.5X5A | Adverse effect of other anti-common-cold drugs, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.5X5D | Adverse effect of other anti-common-cold drugs, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.5X5S | Adverse effect of other anti-common-cold drugs, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.5X6A | Underdosing of other anti-common-cold drugs, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.5X6D | Underdosing of other anti-common-cold drugs, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.5X6S | Underdosing of other anti-common-cold drugs, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.6X5A | Adverse effect of antiasthmatics, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.6X5D | Adverse effect of antiasthmatics, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.6X5S | Adverse effect of antiasthmatics, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.6X6A | Underdosing of antiasthmatics, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.6X6D | Underdosing of antiasthmatics, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.6X6S | Underdosing of antiasthmatics, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.905A | Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.905D | Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.905S | Adverse effect of unspecified agents primarily acting on the respiratory system, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.906A | Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.906D | Underdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.906S | Underdosing of unspecified agents primarily acting on the respiratory system, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.995A | Adverse effect of other agents primarily acting on the respiratory system, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.995D | Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.995S | Adverse effect of other agents primarily acting on the respiratory system, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.996A | Underdosing of other agents primarily acting on the respiratory system, initial encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.996D | Underdosing of other agents primarily acting on the respiratory system, subsequent encounter | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T48.996S | Underdosing of other agents primarily acting on the respiratory system, sequela | Agents prim act on smooth and skeletal musc and the resp sys (T48) |
| T49.0X5A | Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.0X5D | Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.0X5S | Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.0X6A | Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.0X6D | Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.0X6S | Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.1X5A | Adverse effect of antipruritics, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.1X5D | Adverse effect of antipruritics, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.1X5S | Adverse effect of antipruritics, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.1X6A | Underdosing of antipruritics, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.1X6D | Underdosing of antipruritics, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.1X6S | Underdosing of antipruritics, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.2X5A | Adverse effect of local astringents and local detergents, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.2X5D | Adverse effect of local astringents and local detergents, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.2X5S | Adverse effect of local astringents and local detergents, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.2X6A | Underdosing of local astringents and local detergents, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.2X6D | Underdosing of local astringents and local detergents, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.2X6S | Underdosing of local astringents and local detergents, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.3X5A | Adverse effect of emollients, demulcents and protectants, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.3X5D | Adverse effect of emollients, demulcents and protectants, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.3X5S | Adverse effect of emollients, demulcents and protectants, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.3X6A | Underdosing of emollients, demulcents and protectants, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.3X6D | Underdosing of emollients, demulcents and protectants, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.3X6S | Underdosing of emollients, demulcents and protectants, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.4X5A | Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.4X5D | Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.4X5S | Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.4X6A | Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.4X6D | Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.4X6S | Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.5X5A | Adverse effect of ophthalmological drugs and preparations, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.5X5D | Adverse effect of ophthalmological drugs and preparations, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.5X5S | Adverse effect of ophthalmological drugs and preparations, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.5X6A | Underdosing of ophthalmological drugs and preparations, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.5X6D | Underdosing of ophthalmological drugs and preparations, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.5X6S | Underdosing of ophthalmological drugs and preparations, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.6X5A | Adverse effect of otorhinolaryngological drugs and preparations, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.6X5D | Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.6X5S | Adverse effect of otorhinolaryngological drugs and preparations, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.6X6A | Underdosing of otorhinolaryngological drugs and preparations, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.6X6D | Underdosing of otorhinolaryngological drugs and preparations, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.6X6S | Underdosing of otorhinolaryngological drugs and preparations, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.7X5A | Adverse effect of dental drugs, topically applied, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.7X5D | Adverse effect of dental drugs, topically applied, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.7X5S | Adverse effect of dental drugs, topically applied, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.7X6A | Underdosing of dental drugs, topically applied, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.7X6D | Underdosing of dental drugs, topically applied, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.7X6S | Underdosing of dental drugs, topically applied, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.8X5A | Adverse effect of other topical agents, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.8X5D | Adverse effect of other topical agents, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.8X5S | Adverse effect of other topical agents, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.8X6A | Underdosing of other topical agents, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.8X6D | Underdosing of other topical agents, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.8X6S | Underdosing of other topical agents, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.95XA | Adverse effect of unspecified topical agent, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.95XD | Adverse effect of unspecified topical agent, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.95XS | Adverse effect of unspecified topical agent, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T49.96XA | Underdosing of unspecified topical agent, initial encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.96XD | Underdosing of unspecified topical agent, subsequent encounter | Topical skin/eye/ENT/dental drugs (T49) |
| T49.96XS | Underdosing of unspecified topical agent, sequela | Topical skin/eye/ENT/dental drugs (T49) |
| T50.0X5A | Adverse effect of mineralocorticoids and their antagonists, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.0X5D | Adverse effect of mineralocorticoids and their antagonists, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.0X5S | Adverse effect of mineralocorticoids and their antagonists, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.0X6A | Underdosing of mineralocorticoids and their antagonists, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.0X6D | Underdosing of mineralocorticoids and their antagonists, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.0X6S | Underdosing of mineralocorticoids and their antagonists, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.1X5A | Adverse effect of loop [high-ceiling] diuretics, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.1X5D | Adverse effect of loop [high-ceiling] diuretics, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.1X5S | Adverse effect of loop [high-ceiling] diuretics, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.1X6A | Underdosing of loop [high-ceiling] diuretics, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.1X6D | Underdosing of loop [high-ceiling] diuretics, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.1X6S | Underdosing of loop [high-ceiling] diuretics, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.2X5A | Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.2X5D | Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.2X5S | Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.2X6A | Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.2X6D | Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.2X6S | Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.3X5A | Adverse effect of electrolytic, caloric and water-balance agents, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.3X5D | Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.3X5S | Adverse effect of electrolytic, caloric and water-balance agents, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.3X6A | Underdosing of electrolytic, caloric and water-balance agents, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.3X6D | Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.3X6S | Underdosing of electrolytic, caloric and water-balance agents, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.4X5A | Adverse effect of drugs affecting uric acid metabolism, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.4X5D | Adverse effect of drugs affecting uric acid metabolism, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.4X5S | Adverse effect of drugs affecting uric acid metabolism, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.4X6A | Underdosing of drugs affecting uric acid metabolism, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.4X6D | Underdosing of drugs affecting uric acid metabolism, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.4X6S | Underdosing of drugs affecting uric acid metabolism, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.5X5A | Adverse effect of appetite depressants, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.5X5D | Adverse effect of appetite depressants, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.5X5S | Adverse effect of appetite depressants, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.5X6A | Underdosing of appetite depressants, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.5X6D | Underdosing of appetite depressants, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.5X6S | Underdosing of appetite depressants, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.6X5A | Adverse effect of antidotes and chelating agents, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.6X5D | Adverse effect of antidotes and chelating agents, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.6X5S | Adverse effect of antidotes and chelating agents, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.6X6A | Underdosing of antidotes and chelating agents, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.6X6D | Underdosing of antidotes and chelating agents, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.6X6S | Underdosing of antidotes and chelating agents, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.7X5A | Adverse effect of analeptics and opioid receptor antagonists, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.7X5D | Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.7X5S | Adverse effect of analeptics and opioid receptor antagonists, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.7X6A | Underdosing of analeptics and opioid receptor antagonists, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.7X6D | Underdosing of analeptics and opioid receptor antagonists, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.7X6S | Underdosing of analeptics and opioid receptor antagonists, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.8X5A | Adverse effect of diagnostic agents, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.8X5D | Adverse effect of diagnostic agents, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.8X5S | Adverse effect of diagnostic agents, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.8X6A | Underdosing of diagnostic agents, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.8X6D | Underdosing of diagnostic agents, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.8X6S | Underdosing of diagnostic agents, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.915A | Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.915D | Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.915S | Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.916A | Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.916D | Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.916S | Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A15A | Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A15D | Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A15S | Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A16A | Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A16D | Underdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A16S | Underdosing of pertussis vaccine, including combinations with a pertussis component, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A25A | Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A25D | Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A25S | Adverse effect of mixed bacterial vaccines without a pertussis component, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A26A | Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A26D | Underdosing of mixed bacterial vaccines without a pertussis component, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A26S | Underdosing of mixed bacterial vaccines without a pertussis component, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A95A | Adverse effect of other bacterial vaccines, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A95D | Adverse effect of other bacterial vaccines, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A95S | Adverse effect of other bacterial vaccines, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A96A | Underdosing of other bacterial vaccines, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A96D | Underdosing of other bacterial vaccines, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.A96S | Underdosing of other bacterial vaccines, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B15A | Adverse effect of smallpox vaccines, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B15D | Adverse effect of smallpox vaccines, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B15S | Adverse effect of smallpox vaccines, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B16A | Underdosing of smallpox vaccines, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B16D | Underdosing of smallpox vaccines, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B16S | Underdosing of smallpox vaccines, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B95A | Adverse effect of other viral vaccines, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B95D | Adverse effect of other viral vaccines, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B95S | Adverse effect of other viral vaccines, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B96A | Underdosing of other viral vaccines, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B96D | Underdosing of other viral vaccines, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.B96S | Underdosing of other viral vaccines, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z15A | Adverse effect of immunoglobulin, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z15D | Adverse effect of immunoglobulin, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z15S | Adverse effect of immunoglobulin, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z16A | Underdosing of immunoglobulin, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z16D | Underdosing of immunoglobulin, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z16S | Underdosing of immunoglobulin, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z95A | Adverse effect of other vaccines and biological substances, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z95D | Adverse effect of other vaccines and biological substances, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z95S | Adverse effect of other vaccines and biological substances, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z96A | Underdosing of other vaccines and biological substances, initial encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z96D | Underdosing of other vaccines and biological substances, subsequent encounter | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T50.Z96S | Underdosing of other vaccines and biological substances, sequela | Diuretics and oth and unsp drug/meds/biol subst (T50) |
| T81.12XA | Postprocedural septic shock, initial encounter | Complications of procedures, not elsewhere classified (T81) |
| T81.12XD | Postprocedural septic shock, subsequent encounter | Complications of procedures, not elsewhere classified (T81) |
| T81.12XS | Postprocedural septic shock, sequela | Complications of procedures, not elsewhere classified (T81) |
| Z00.00 | Encounter for general adult medical examination without abnormal findings | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.01 | Encounter for general adult medical examination with abnormal findings | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.110 | Health examination for newborn under 8 days old | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.111 | Health examination for newborn 8 to 28 days old | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.121 | Encounter for routine child health examination with abnormal findings | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.129 | Encounter for routine child health examination without abnormal findings | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.2 | Encounter for examination for period of rapid growth in childhood | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.3 | Encounter for examination for adolescent development state | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.5 | Encounter for examination of potential donor of organ and tissue | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.70 | Encounter for examination for period of delayed growth in childhood without abnormal findings | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.71 | Encounter for examination for period of delayed growth in childhood with abnormal findings | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z00.8 | Encounter for other general examination | Encntr for general exam w/o complaint, susp or reprtd dx (Z00) |
| Z01.10 | Encounter for examination of ears and hearing without abnormal findings | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.110 | Encounter for hearing examination following failed hearing screening | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.118 | Encounter for examination of ears and hearing with other abnormal findings | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.12 | Encounter for hearing conservation and treatment | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.20 | Encounter for dental examination and cleaning without abnormal findings | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.21 | Encounter for dental examination and cleaning with abnormal findings | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.30 | Encounter for examination of blood pressure without abnormal findings | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.31 | Encounter for examination of blood pressure with abnormal findings | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.812 | Encounter for preprocedural laboratory examination | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.818 | Encounter for other preprocedural examination | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.82 | Encounter for allergy testing | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.83 | Encounter for blood typing | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.84 | Encounter for antibody response examination | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z01.89 | Encounter for other specified special examinations | Encntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01) |
| Z02.0 | Encounter for examination for admission to educational institution | Encounter for administrative examination (Z02) |
| Z02.2 | Encounter for examination for admission to residential institution | Encounter for administrative examination (Z02) |
| Z02.4 | Encounter for examination for driving license | Encounter for administrative examination (Z02) |
| Z02.5 | Encounter for examination for participation in sport | Encounter for administrative examination (Z02) |
| Z02.6 | Encounter for examination for insurance purposes | Encounter for administrative examination (Z02) |
| Z02.71 | Encounter for disability determination | Encounter for administrative examination (Z02) |
| Z02.79 | Encounter for issue of other medical certificate | Encounter for administrative examination (Z02) |
| Z02.82 | Encounter for adoption services | Encounter for administrative examination (Z02) |
| Z02.89 | Encounter for other administrative examinations | Encounter for administrative examination (Z02) |
| Z02.9 | Encounter for administrative examinations, unspecified | Encounter for administrative examination (Z02) |
| Z03.71 | Encounter for suspected problem with amniotic cavity and membrane ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.72 | Encounter for suspected placental problem ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.73 | Encounter for suspected fetal anomaly ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.74 | Encounter for suspected problem with fetal growth ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.75 | Encounter for suspected cervical shortening ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.79 | Encounter for other suspected maternal and fetal conditions ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.821 | Encounter for observation for suspected ingested foreign body ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.822 | Encounter for observation for suspected aspirated (inhaled) foreign body ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z03.823 | Encounter for observation for suspected inserted (injected) foreign body ruled out | Encntr for medical obs for susp diseases and cond ruled out (Z03) |
| Z04.9 | Encounter for examination and observation for unspecified reason | Encounter for examination and observation for other reasons (Z04) |
| Z08 | Encounter for follow-up examination after completed treatment for malignant neoplasm | Encntr for follow-up exam after trtmt for malignant neoplasm (Z08) |
| Z09 | Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | Encntr for f/u exam aft trtmt for cond oth than malig neoplm (Z09) |
| Z11.0 | Encounter for screening for intestinal infectious diseases | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.1 | Encounter for screening for respiratory tuberculosis | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.2 | Encounter for screening for other bacterial diseases | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.3 | Encounter for screening for infections with a predominantly sexual mode of transmission | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.4 | Encounter for screening for human immunodeficiency virus [HIV] | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.51 | Encounter for screening for human papillomavirus (HPV) | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.52 | Encounter for screening for COVID-19 | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.59 | Encounter for screening for other viral diseases | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.6 | Encounter for screening for other protozoal diseases and helminthiases | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.7 | Encounter for testing for latent tuberculosis infection | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.8 | Encounter for screening for other infectious and parasitic diseases | Encounter for screening for infec/parastc diseases (Z11) |
| Z11.9 | Encounter for screening for infectious and parasitic diseases, unspecified | Encounter for screening for infec/parastc diseases (Z11) |
| Z12.0 | Encounter for screening for malignant neoplasm of stomach | Encounter for screening for malignant neoplasms (Z12) |
| Z12.10 | Encounter for screening for malignant neoplasm of intestinal tract, unspecified | Encounter for screening for malignant neoplasms (Z12) |
| Z12.11 | Encounter for screening for malignant neoplasm of colon | Encounter for screening for malignant neoplasms (Z12) |
| Z12.12 | Encounter for screening for malignant neoplasm of rectum | Encounter for screening for malignant neoplasms (Z12) |
| Z12.13 | Encounter for screening for malignant neoplasm of small intestine | Encounter for screening for malignant neoplasms (Z12) |
| Z12.2 | Encounter for screening for malignant neoplasm of respiratory organs | Encounter for screening for malignant neoplasms (Z12) |
| Z12.31 | Encounter for screening mammogram for malignant neoplasm of breast | Encounter for screening for malignant neoplasms (Z12) |
| Z12.39 | Encounter for other screening for malignant neoplasm of breast | Encounter for screening for malignant neoplasms (Z12) |
| Z12.4 | Encounter for screening for malignant neoplasm of cervix | Encounter for screening for malignant neoplasms (Z12) |
| Z12.6 | Encounter for screening for malignant neoplasm of bladder | Encounter for screening for malignant neoplasms (Z12) |
| Z12.71 | Encounter for screening for malignant neoplasm of testis | Encounter for screening for malignant neoplasms (Z12) |
| Z12.72 | Encounter for screening for malignant neoplasm of vagina | Encounter for screening for malignant neoplasms (Z12) |
| Z12.73 | Encounter for screening for malignant neoplasm of ovary | Encounter for screening for malignant neoplasms (Z12) |
| Z12.79 | Encounter for screening for malignant neoplasm of other genitourinary organs | Encounter for screening for malignant neoplasms (Z12) |
| Z12.81 | Encounter for screening for malignant neoplasm of oral cavity | Encounter for screening for malignant neoplasms (Z12) |
| Z12.82 | Encounter for screening for malignant neoplasm of nervous system | Encounter for screening for malignant neoplasms (Z12) |
| Z12.83 | Encounter for screening for malignant neoplasm of skin | Encounter for screening for malignant neoplasms (Z12) |
| Z12.89 | Encounter for screening for malignant neoplasm of other sites | Encounter for screening for malignant neoplasms (Z12) |
| Z12.9 | Encounter for screening for malignant neoplasm, site unspecified | Encounter for screening for malignant neoplasms (Z12) |
| Z13.0 | Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Encounter for screening for other diseases and disorders (Z13) |
| Z13.1 | Encounter for screening for diabetes mellitus | Encounter for screening for other diseases and disorders (Z13) |
| Z13.21 | Encounter for screening for nutritional disorder | Encounter for screening for other diseases and disorders (Z13) |
| Z13.220 | Encounter for screening for lipoid disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.228 | Encounter for screening for other metabolic disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.29 | Encounter for screening for other suspected endocrine disorder | Encounter for screening for other diseases and disorders (Z13) |
| Z13.30 | Encounter for screening examination for mental health and behavioral disorders, unspecified | Encounter for screening for other diseases and disorders (Z13) |
| Z13.31 | Encounter for screening for depression | Encounter for screening for other diseases and disorders (Z13) |
| Z13.32 | Encounter for screening for maternal depression | Encounter for screening for other diseases and disorders (Z13) |
| Z13.39 | Encounter for screening examination for other mental health and behavioral disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.40 | Encounter for screening for unspecified developmental delays | Encounter for screening for other diseases and disorders (Z13) |
| Z13.41 | Encounter for autism screening | Encounter for screening for other diseases and disorders (Z13) |
| Z13.42 | Encounter for screening for global developmental delays (milestones) | Encounter for screening for other diseases and disorders (Z13) |
| Z13.49 | Encounter for screening for other developmental delays | Encounter for screening for other diseases and disorders (Z13) |
| Z13.5 | Encounter for screening for eye and ear disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.6 | Encounter for screening for cardiovascular disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.71 | Encounter for nonprocreative screening for genetic disease carrier status | Encounter for screening for other diseases and disorders (Z13) |
| Z13.79 | Encounter for other screening for genetic and chromosomal anomalies | Encounter for screening for other diseases and disorders (Z13) |
| Z13.810 | Encounter for screening for upper gastrointestinal disorder | Encounter for screening for other diseases and disorders (Z13) |
| Z13.811 | Encounter for screening for lower gastrointestinal disorder | Encounter for screening for other diseases and disorders (Z13) |
| Z13.818 | Encounter for screening for other digestive system disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.820 | Encounter for screening for osteoporosis | Encounter for screening for other diseases and disorders (Z13) |
| Z13.828 | Encounter for screening for other musculoskeletal disorder | Encounter for screening for other diseases and disorders (Z13) |
| Z13.83 | Encounter for screening for respiratory disorder NEC | Encounter for screening for other diseases and disorders (Z13) |
| Z13.84 | Encounter for screening for dental disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.850 | Encounter for screening for traumatic brain injury | Encounter for screening for other diseases and disorders (Z13) |
| Z13.858 | Encounter for screening for other nervous system disorders | Encounter for screening for other diseases and disorders (Z13) |
| Z13.88 | Encounter for screening for disorder due to exposure to contaminants | Encounter for screening for other diseases and disorders (Z13) |
| Z13.89 | Encounter for screening for other disorder | Encounter for screening for other diseases and disorders (Z13) |
| Z13.9 | Encounter for screening, unspecified | Encounter for screening for other diseases and disorders (Z13) |
| Z14.01 | Asymptomatic hemophilia A carrier | Genetic carrier (Z14) |
| Z14.02 | Symptomatic hemophilia A carrier | Genetic carrier (Z14) |
| Z14.1 | Cystic fibrosis carrier | Genetic carrier (Z14) |
| Z14.8 | Genetic carrier of other disease | Genetic carrier (Z14) |
| Z15.01 | Genetic susceptibility to malignant neoplasm of breast | Genetic susceptibility to disease (Z15) |
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary | Genetic susceptibility to disease (Z15) |
| Z15.03 | Genetic susceptibility to malignant neoplasm of prostate | Genetic susceptibility to disease (Z15) |
| Z15.04 | Genetic susceptibility to malignant neoplasm of endometrium | Genetic susceptibility to disease (Z15) |
| Z15.09 | Genetic susceptibility to other malignant neoplasm | Genetic susceptibility to disease (Z15) |
| Z15.81 | Genetic susceptibility to multiple endocrine neoplasia [MEN] | Genetic susceptibility to disease (Z15) |
| Z15.89 | Genetic susceptibility to other disease | Genetic susceptibility to disease (Z15) |
| Z16.10 | Resistance to unspecified beta lactam antibiotics | Resistance to antimicrobial drugs (Z16) |
| Z16.11 | Resistance to penicillins | Resistance to antimicrobial drugs (Z16) |
| Z16.12 | Extended spectrum beta lactamase (ESBL) resistance | Resistance to antimicrobial drugs (Z16) |
| Z16.19 | Resistance to other specified beta lactam antibiotics | Resistance to antimicrobial drugs (Z16) |
| Z16.20 | Resistance to unspecified antibiotic | Resistance to antimicrobial drugs (Z16) |
| Z16.21 | Resistance to vancomycin | Resistance to antimicrobial drugs (Z16) |
| Z16.22 | Resistance to vancomycin related antibiotics | Resistance to antimicrobial drugs (Z16) |
| Z16.23 | Resistance to quinolones and fluoroquinolones | Resistance to antimicrobial drugs (Z16) |
| Z16.24 | Resistance to multiple antibiotics | Resistance to antimicrobial drugs (Z16) |
| Z16.29 | Resistance to other single specified antibiotic | Resistance to antimicrobial drugs (Z16) |
| Z16.30 | Resistance to unspecified antimicrobial drugs | Resistance to antimicrobial drugs (Z16) |
| Z16.31 | Resistance to antiparasitic drug(s) | Resistance to antimicrobial drugs (Z16) |
| Z16.32 | Resistance to antifungal drug(s) | Resistance to antimicrobial drugs (Z16) |
| Z16.33 | Resistance to antiviral drug(s) | Resistance to antimicrobial drugs (Z16) |
| Z16.341 | Resistance to single antimycobacterial drug | Resistance to antimicrobial drugs (Z16) |
| Z16.342 | Resistance to multiple antimycobacterial drugs | Resistance to antimicrobial drugs (Z16) |
| Z16.35 | Resistance to multiple antimicrobial drugs | Resistance to antimicrobial drugs (Z16) |
| Z16.39 | Resistance to other specified antimicrobial drug | Resistance to antimicrobial drugs (Z16) |
| Z17.0 | Estrogen receptor positive status [ER+] | Estrogen receptor status (Z17) |
| Z17.1 | Estrogen receptor negative status [ER-] | Estrogen receptor status (Z17) |
| Z18.01 | Retained depleted uranium fragments | Retained foreign body fragments (Z18) |
| Z18.09 | Other retained radioactive fragments | Retained foreign body fragments (Z18) |
| Z18.10 | Retained metal fragments, unspecified | Retained foreign body fragments (Z18) |
| Z18.11 | Retained magnetic metal fragments | Retained foreign body fragments (Z18) |
| Z18.12 | Retained nonmagnetic metal fragments | Retained foreign body fragments (Z18) |
| Z18.2 | Retained plastic fragments | Retained foreign body fragments (Z18) |
| Z18.31 | Retained animal quills or spines | Retained foreign body fragments (Z18) |
| Z18.32 | Retained tooth | Retained foreign body fragments (Z18) |
| Z18.33 | Retained wood fragments | Retained foreign body fragments (Z18) |
| Z18.39 | Other retained organic fragments | Retained foreign body fragments (Z18) |
| Z18.81 | Retained glass fragments | Retained foreign body fragments (Z18) |
| Z18.83 | Retained stone or crystalline fragments | Retained foreign body fragments (Z18) |
| Z18.89 | Other specified retained foreign body fragments | Retained foreign body fragments (Z18) |
| Z18.9 | Retained foreign body fragments, unspecified material | Retained foreign body fragments (Z18) |
| Z19.1 | Hormone sensitive malignancy status | Hormone sensitivity malignancy status (Z19) |
| Z19.2 | Hormone resistant malignancy status | Hormone sensitivity malignancy status (Z19) |
| Z20.09 | Contact with and (suspected) exposure to other intestinal infectious diseases | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.1 | Contact with and (suspected) exposure to tuberculosis | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.2 | Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.3 | Contact with and (suspected) exposure to rabies | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.4 | Contact with and (suspected) exposure to rubella | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.7 | Contact with and (suspected) exposure to pediculosis, acariasis and other infestations | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.810 | Contact with and (suspected) exposure to anthrax | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.818 | Contact with and (suspected) exposure to other bacterial communicable diseases | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.821 | Contact with and (suspected) exposure to Zika virus | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.822 | Contact with and (suspected) exposure to COVID-19 | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.89 | Contact with and (suspected) exposure to other communicable diseases | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z20.9 | Contact with and (suspected) exposure to unspecified communicable disease | Contact w and (suspected) exposure to communicable diseases (Z20) |
| Z22.0 | Carrier of typhoid | Carrier of infectious disease (Z22) |
| Z22.1 | Carrier of other intestinal infectious diseases | Carrier of infectious disease (Z22) |
| Z22.2 | Carrier of diphtheria | Carrier of infectious disease (Z22) |
| Z22.31 | Carrier of bacterial disease due to meningococci | Carrier of infectious disease (Z22) |
| Z22.321 | Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureus | Carrier of infectious disease (Z22) |
| Z22.322 | Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus | Carrier of infectious disease (Z22) |
| Z22.330 | Carrier of Group B streptococcus | Carrier of infectious disease (Z22) |
| Z22.338 | Carrier of other streptococcus | Carrier of infectious disease (Z22) |
| Z22.39 | Carrier of other specified bacterial diseases | Carrier of infectious disease (Z22) |
| Z22.4 | Carrier of infections with a predominantly sexual mode of transmission | Carrier of infectious disease (Z22) |
| Z22.6 | Carrier of human T-lymphotropic virus type-1 [HTLV-1] infection | Carrier of infectious disease (Z22) |
| Z22.7 | Latent tuberculosis | Carrier of infectious disease (Z22) |
| Z22.8 | Carrier of other infectious diseases | Carrier of infectious disease (Z22) |
| Z22.9 | Carrier of infectious disease, unspecified | Carrier of infectious disease (Z22) |
| Z23 | Encounter for immunization | Encounter for immunization (Z23) |
| Z28.01 | Immunization not carried out because of acute illness of patient | Immunization not carried out and underimmunization status (Z28) |
| Z28.02 | Immunization not carried out because of chronic illness or condition of patient | Immunization not carried out and underimmunization status (Z28) |
| Z28.03 | Immunization not carried out because of immune compromised state of patient | Immunization not carried out and underimmunization status (Z28) |
| Z28.04 | Immunization not carried out because of patient allergy to vaccine or component | Immunization not carried out and underimmunization status (Z28) |
| Z28.09 | Immunization not carried out because of other contraindication | Immunization not carried out and underimmunization status (Z28) |
| Z28.1 | Immunization not carried out because of patient decision for reasons of belief or group pressure | Immunization not carried out and underimmunization status (Z28) |
| Z28.20 | Immunization not carried out because of patient decision for unspecified reason | Immunization not carried out and underimmunization status (Z28) |
| Z28.21 | Immunization not carried out because of patient refusal | Immunization not carried out and underimmunization status (Z28) |
| Z28.29 | Immunization not carried out because of patient decision for other reason | Immunization not carried out and underimmunization status (Z28) |
| Z28.3 | Underimmunization status | Immunization not carried out and underimmunization status (Z28) |
| Z28.81 | Immunization not carried out due to patient having had the disease | Immunization not carried out and underimmunization status (Z28) |
| Z28.82 | Immunization not carried out because of caregiver refusal | Immunization not carried out and underimmunization status (Z28) |
| Z28.83 | Immunization not carried out due to unavailability of vaccine | Immunization not carried out and underimmunization status (Z28) |
| Z28.89 | Immunization not carried out for other reason | Immunization not carried out and underimmunization status (Z28) |
| Z28.9 | Immunization not carried out for unspecified reason | Immunization not carried out and underimmunization status (Z28) |
| Z29.11 | Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) | Encounter for other prophylactic measures (Z29) |
| Z29.12 | Encounter for prophylactic antivenin | Encounter for other prophylactic measures (Z29) |
| Z29.13 | Encounter for prophylactic Rho(D) immune globulin | Encounter for other prophylactic measures (Z29) |
| Z29.14 | Encounter for prophylactic rabies immune globin | Encounter for other prophylactic measures (Z29) |
| Z29.3 | Encounter for prophylactic fluoride administration | Encounter for other prophylactic measures (Z29) |
| Z29.8 | Encounter for other specified prophylactic measures | Encounter for other prophylactic measures (Z29) |
| Z29.9 | Encounter for prophylactic measures, unspecified | Encounter for other prophylactic measures (Z29) |
| Z30.011 | Encounter for initial prescription of contraceptive pills | Encounter for contraceptive management (Z30) |
| Z30.012 | Encounter for prescription of emergency contraception | Encounter for contraceptive management (Z30) |
| Z30.013 | Encounter for initial prescription of injectable contraceptive | Encounter for contraceptive management (Z30) |
| Z30.014 | Encounter for initial prescription of intrauterine contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.015 | Encounter for initial prescription of vaginal ring hormonal contraceptive | Encounter for contraceptive management (Z30) |
| Z30.016 | Encounter for initial prescription of transdermal patch hormonal contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.017 | Encounter for initial prescription of implantable subdermal contraceptive | Encounter for contraceptive management (Z30) |
| Z30.018 | Encounter for initial prescription of other contraceptives | Encounter for contraceptive management (Z30) |
| Z30.019 | Encounter for initial prescription of contraceptives, unspecified | Encounter for contraceptive management (Z30) |
| Z30.02 | Counseling and instruction in natural family planning to avoid pregnancy | Encounter for contraceptive management (Z30) |
| Z30.09 | Encounter for other general counseling and advice on contraception | Encounter for contraceptive management (Z30) |
| Z30.40 | Encounter for surveillance of contraceptives, unspecified | Encounter for contraceptive management (Z30) |
| Z30.41 | Encounter for surveillance of contraceptive pills | Encounter for contraceptive management (Z30) |
| Z30.42 | Encounter for surveillance of injectable contraceptive | Encounter for contraceptive management (Z30) |
| Z30.430 | Encounter for insertion of intrauterine contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.431 | Encounter for routine checking of intrauterine contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.432 | Encounter for removal of intrauterine contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.433 | Encounter for removal and reinsertion of intrauterine contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.44 | Encounter for surveillance of vaginal ring hormonal contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.45 | Encounter for surveillance of transdermal patch hormonal contraceptive device | Encounter for contraceptive management (Z30) |
| Z30.46 | Encounter for surveillance of implantable subdermal contraceptive | Encounter for contraceptive management (Z30) |
| Z30.49 | Encounter for surveillance of other contraceptives | Encounter for contraceptive management (Z30) |
| Z30.8 | Encounter for other contraceptive management | Encounter for contraceptive management (Z30) |
| Z30.9 | Encounter for contraceptive management, unspecified | Encounter for contraceptive management (Z30) |
| Z31.41 | Encounter for fertility testing | Encounter for procreative management (Z31) |
| Z31.42 | Aftercare following sterilization reversal | Encounter for procreative management (Z31) |
| Z31.430 | Encounter of female for testing for genetic disease carrier status for procreative management | Encounter for procreative management (Z31) |
| Z31.438 | Encounter for other genetic testing of female for procreative management | Encounter for procreative management (Z31) |
| Z31.440 | Encounter of male for testing for genetic disease carrier status for procreative management | Encounter for procreative management (Z31) |
| Z31.441 | Encounter for testing of male partner of patient with recurrent pregnancy loss | Encounter for procreative management (Z31) |
| Z31.448 | Encounter for other genetic testing of male for procreative management | Encounter for procreative management (Z31) |
| Z31.49 | Encounter for other procreative investigation and testing | Encounter for procreative management (Z31) |
| Z31.5 | Encounter for procreative genetic counseling | Encounter for procreative management (Z31) |
| Z31.61 | Procreative counseling and advice using natural family planning | Encounter for procreative management (Z31) |
| Z31.62 | Encounter for fertility preservation counseling | Encounter for procreative management (Z31) |
| Z31.69 | Encounter for other general counseling and advice on procreation | Encounter for procreative management (Z31) |
| Z31.7 | Encounter for procreative management and counseling for gestational carrier | Encounter for procreative management (Z31) |
| Z31.81 | Encounter for male factor infertility in female patient | Encounter for procreative management (Z31) |
| Z31.82 | Encounter for Rh incompatibility status | Encounter for procreative management (Z31) |
| Z31.83 | Encounter for assisted reproductive fertility procedure cycle | Encounter for procreative management (Z31) |
| Z31.84 | Encounter for fertility preservation procedure | Encounter for procreative management (Z31) |
| Z31.89 | Encounter for other procreative management | Encounter for procreative management (Z31) |
| Z31.9 | Encounter for procreative management, unspecified | Encounter for procreative management (Z31) |
| Z32.2 | Encounter for childbirth instruction | Encntr for preg test and chldbrth and childcare instruction (Z32) |
| Z32.3 | Encounter for childcare instruction | Encntr for preg test and chldbrth and childcare instruction (Z32) |
| Z33.1 | Pregnant state, incidental | Pregnant state (Z33) |
| Z33.3 | Pregnant state, gestational carrier | Pregnant state (Z33) |
| Z34.00 | Encounter for supervision of normal first pregnancy, unspecified trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.01 | Encounter for supervision of normal first pregnancy, first trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.02 | Encounter for supervision of normal first pregnancy, second trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.03 | Encounter for supervision of normal first pregnancy, third trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.80 | Encounter for supervision of other normal pregnancy, unspecified trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.81 | Encounter for supervision of other normal pregnancy, first trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.82 | Encounter for supervision of other normal pregnancy, second trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.83 | Encounter for supervision of other normal pregnancy, third trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.90 | Encounter for supervision of normal pregnancy, unspecified, unspecified trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.91 | Encounter for supervision of normal pregnancy, unspecified, first trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.92 | Encounter for supervision of normal pregnancy, unspecified, second trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z34.93 | Encounter for supervision of normal pregnancy, unspecified, third trimester | Encounter for supervision of normal pregnancy (Z34) |
| Z37.0 | Single live birth | Outcome of delivery (Z37) |
| Z37.1 | Single stillbirth | Outcome of delivery (Z37) |
| Z37.2 | Twins, both liveborn | Outcome of delivery (Z37) |
| Z37.3 | Twins, one liveborn and one stillborn | Outcome of delivery (Z37) |
| Z37.4 | Twins, both stillborn | Outcome of delivery (Z37) |
| Z37.50 | Multiple births, unspecified, all liveborn | Outcome of delivery (Z37) |
| Z37.51 | Triplets, all liveborn | Outcome of delivery (Z37) |
| Z37.52 | Quadruplets, all liveborn | Outcome of delivery (Z37) |
| Z37.53 | Quintuplets, all liveborn | Outcome of delivery (Z37) |
| Z37.54 | Sextuplets, all liveborn | Outcome of delivery (Z37) |
| Z37.59 | Other multiple births, all liveborn | Outcome of delivery (Z37) |
| Z37.60 | Multiple births, unspecified, some liveborn | Outcome of delivery (Z37) |
| Z37.61 | Triplets, some liveborn | Outcome of delivery (Z37) |
| Z37.62 | Quadruplets, some liveborn | Outcome of delivery (Z37) |
| Z37.63 | Quintuplets, some liveborn | Outcome of delivery (Z37) |
| Z37.64 | Sextuplets, some liveborn | Outcome of delivery (Z37) |
| Z37.69 | Other multiple births, some liveborn | Outcome of delivery (Z37) |
| Z37.7 | Other multiple births, all stillborn | Outcome of delivery (Z37) |
| Z37.9 | Outcome of delivery, unspecified | Outcome of delivery (Z37) |
| Z39.1 | Encounter for care and examination of lactating mother | Encounter for maternal postpartum care and examination (Z39) |
| Z39.2 | Encounter for routine postpartum follow-up | Encounter for maternal postpartum care and examination (Z39) |
| Z3A.00 | Weeks of gestation of pregnancy not specified | Weeks of gestation (Z3A) |
| Z3A.01 | Less than 8 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.08 | 8 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.09 | 9 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.10 | 10 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.11 | 11 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.12 | 12 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.13 | 13 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.14 | 14 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.15 | 15 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.16 | 16 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.17 | 17 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.18 | 18 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.19 | 19 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.20 | 20 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.21 | 21 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.22 | 22 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.23 | 23 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.24 | 24 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.25 | 25 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.26 | 26 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.27 | 27 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.28 | 28 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.29 | 29 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.30 | 30 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.31 | 31 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.32 | 32 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.33 | 33 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.34 | 34 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.35 | 35 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.36 | 36 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.37 | 37 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.38 | 38 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.39 | 39 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.40 | 40 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.41 | 41 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.42 | 42 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z3A.49 | Greater than 42 weeks gestation of pregnancy | Weeks of gestation (Z3A) |
| Z40.8 | Encounter for other prophylactic surgery | Encounter for prophylactic surgery (Z40) |
| Z40.9 | Encounter for prophylactic surgery, unspecified | Encounter for prophylactic surgery (Z40) |
| Z41.3 | Encounter for ear piercing | Encntr for proc for purposes oth than remedying health state (Z41) |
| Z41.9 | Encounter for procedure for purposes other than remedying health state, unspecified | Encntr for proc for purposes oth than remedying health state (Z41) |
| Z43.9 | Encounter for attention to unspecified artificial opening | Encounter for attention to artificial openings (Z43) |
| Z44.9 | Encounter for fitting and adjustment of unspecified external prosthetic device | Encounter for fit/adjst of external prosthetic device (Z44) |
| Z45.82 | Encounter for adjustment or removal of myringotomy device (stent) (tube) | Encounter for adjustment and management of implanted device (Z45) |
| Z45.89 | Encounter for adjustment and management of other implanted devices | Encounter for adjustment and management of implanted device (Z45) |
| Z45.9 | Encounter for adjustment and management of unspecified implanted device | Encounter for adjustment and management of implanted device (Z45) |
| Z46.0 | Encounter for fitting and adjustment of spectacles and contact lenses | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.1 | Encounter for fitting and adjustment of hearing aid | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.4 | Encounter for fitting and adjustment of orthodontic device | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.51 | Encounter for fitting and adjustment of gastric lap band | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.59 | Encounter for fitting and adjustment of other gastrointestinal appliance and device | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.6 | Encounter for fitting and adjustment of urinary device | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.81 | Encounter for fitting and adjustment of insulin pump | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.89 | Encounter for fitting and adjustment of other specified devices | Encounter for fitting and adjustment of other devices (Z46) |
| Z46.9 | Encounter for fitting and adjustment of unspecified device | Encounter for fitting and adjustment of other devices (Z46) |
| Z48.00 | Encounter for change or removal of nonsurgical wound dressing | Encounter for other postprocedural aftercare (Z48) |
| Z48.01 | Encounter for change or removal of surgical wound dressing | Encounter for other postprocedural aftercare (Z48) |
| Z48.02 | Encounter for removal of sutures | Encounter for other postprocedural aftercare (Z48) |
| Z49.01 | Encounter for fitting and adjustment of extracorporeal dialysis catheter | Encounter for care involving renal dialysis (Z49) |
| Z49.02 | Encounter for fitting and adjustment of peritoneal dialysis catheter | Encounter for care involving renal dialysis (Z49) |
| Z49.31 | Encounter for adequacy testing for hemodialysis | Encounter for care involving renal dialysis (Z49) |
| Z49.32 | Encounter for adequacy testing for peritoneal dialysis | Encounter for care involving renal dialysis (Z49) |
| Z51.6 | Encounter for desensitization to allergens | Encounter for other aftercare and medical care (Z51) |
| Z51.89 | Encounter for other specified aftercare | Encounter for other aftercare and medical care (Z51) |
| Z52.000 | Unspecified donor, whole blood | Donors of organs and tissues (Z52) |
| Z52.001 | Unspecified donor, stem cells | Donors of organs and tissues (Z52) |
| Z52.008 | Unspecified donor, other blood | Donors of organs and tissues (Z52) |
| Z52.010 | Autologous donor, whole blood | Donors of organs and tissues (Z52) |
| Z52.011 | Autologous donor, stem cells | Donors of organs and tissues (Z52) |
| Z52.018 | Autologous donor, other blood | Donors of organs and tissues (Z52) |
| Z52.090 | Other blood donor, whole blood | Donors of organs and tissues (Z52) |
| Z52.091 | Other blood donor, stem cells | Donors of organs and tissues (Z52) |
| Z52.098 | Other blood donor, other blood | Donors of organs and tissues (Z52) |
| Z52.810 | Egg (Oocyte) donor under age 35, anonymous recipient | Donors of organs and tissues (Z52) |
| Z52.811 | Egg (Oocyte) donor under age 35, designated recipient | Donors of organs and tissues (Z52) |
| Z52.812 | Egg (Oocyte) donor age 35 and over, anonymous recipient | Donors of organs and tissues (Z52) |
| Z52.813 | Egg (Oocyte) donor age 35 and over, designated recipient | Donors of organs and tissues (Z52) |
| Z52.819 | Egg (Oocyte) donor, unspecified | Donors of organs and tissues (Z52) |
| Z53.01 | Procedure and treatment not carried out due to patient smoking | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.09 | Procedure and treatment not carried out because of other contraindication | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.1 | Procedure and treatment not carried out because of patient's decision for reasons of belief and group pressure | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.20 | Procedure and treatment not carried out because of patient's decision for unspecified reasons | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.21 | Procedure and treatment not carried out due to patient leaving prior to being seen by health care provider | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.29 | Procedure and treatment not carried out because of patient's decision for other reasons | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.31 | Laparoscopic surgical procedure converted to open procedure | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.32 | Thoracoscopic surgical procedure converted to open procedure | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.33 | Arthroscopic surgical procedure converted to open procedure | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.39 | Other specified procedure converted to open procedure | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.8 | Procedure and treatment not carried out for other reasons | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z53.9 | Procedure and treatment not carried out, unspecified reason | Persons encntr hlth serv for spec proc & trtmt, not crd out (Z53) |
| Z55.0 | Illiteracy and low-level literacy | Problems related to education and literacy (Z55) |
| Z55.1 | Schooling unavailable and unattainable | Problems related to education and literacy (Z55) |
| Z55.2 | Failed school examinations | Problems related to education and literacy (Z55) |
| Z55.3 | Underachievement in school | Problems related to education and literacy (Z55) |
| Z55.4 | Educational maladjustment and discord with teachers and classmates | Problems related to education and literacy (Z55) |
| Z55.5 | Less than a high school diploma | Problems related to education and literacy (Z55) |
| Z55.8 | Other problems related to education and literacy | Problems related to education and literacy (Z55) |
| Z55.9 | Problems related to education and literacy, unspecified | Problems related to education and literacy (Z55) |
| Z56.0 | Unemployment, unspecified | Problems related to employment and unemployment (Z56) |
| Z56.1 | Change of job | Problems related to employment and unemployment (Z56) |
| Z56.2 | Threat of job loss | Problems related to employment and unemployment (Z56) |
| Z56.3 | Stressful work schedule | Problems related to employment and unemployment (Z56) |
| Z56.4 | Discord with boss and workmates | Problems related to employment and unemployment (Z56) |
| Z56.5 | Uncongenial work environment | Problems related to employment and unemployment (Z56) |
| Z56.6 | Other physical and mental strain related to work | Problems related to employment and unemployment (Z56) |
| Z56.81 | Sexual harassment on the job | Problems related to employment and unemployment (Z56) |
| Z56.82 | Military deployment status | Problems related to employment and unemployment (Z56) |
| Z56.89 | Other problems related to employment | Problems related to employment and unemployment (Z56) |
| Z56.9 | Unspecified problems related to employment | Problems related to employment and unemployment (Z56) |
| Z57.0 | Occupational exposure to noise | Occupational exposure to risk factors (Z57) |
| Z57.1 | Occupational exposure to radiation | Occupational exposure to risk factors (Z57) |
| Z57.2 | Occupational exposure to dust | Occupational exposure to risk factors (Z57) |
| Z57.31 | Occupational exposure to environmental tobacco smoke | Occupational exposure to risk factors (Z57) |
| Z57.39 | Occupational exposure to other air contaminants | Occupational exposure to risk factors (Z57) |
| Z57.4 | Occupational exposure to toxic agents in agriculture | Occupational exposure to risk factors (Z57) |
| Z57.5 | Occupational exposure to toxic agents in other industries | Occupational exposure to risk factors (Z57) |
| Z57.6 | Occupational exposure to extreme temperature | Occupational exposure to risk factors (Z57) |
| Z57.7 | Occupational exposure to vibration | Occupational exposure to risk factors (Z57) |
| Z57.8 | Occupational exposure to other risk factors | Occupational exposure to risk factors (Z57) |
| Z57.9 | Occupational exposure to unspecified risk factor | Occupational exposure to risk factors (Z57) |
| Z58.6 | Inadequate drinking-water supply | Problems related to physical environment (Z58) |
| Z59.00 | Homelessness unspecified | Problems related to housing and economic circumstances (Z59) |
| Z59.01 | Sheltered homelessness | Problems related to housing and economic circumstances (Z59) |
| Z59.02 | Unsheltered homelessness | Problems related to housing and economic circumstances (Z59) |
| Z59.1 | Inadequate housing | Problems related to housing and economic circumstances (Z59) |
| Z59.2 | Discord with neighbors, lodgers and landlord | Problems related to housing and economic circumstances (Z59) |
| Z59.3 | Problems related to living in residential institution | Problems related to housing and economic circumstances (Z59) |
| Z59.41 | Food insecurity | Problems related to housing and economic circumstances (Z59) |
| Z59.48 | Other specified lack of adequate food | Problems related to housing and economic circumstances (Z59) |
| Z59.5 | Extreme poverty | Problems related to housing and economic circumstances (Z59) |
| Z59.6 | Low income | Problems related to housing and economic circumstances (Z59) |
| Z59.7 | Insufficient social insurance and welfare support | Problems related to housing and economic circumstances (Z59) |
| Z59.811 | Housing instability, housed, with risk of homelessness | Problems related to housing and economic circumstances (Z59) |
| Z59.812 | Housing instability, housed, homelessness in past 12 months | Problems related to housing and economic circumstances (Z59) |
| Z59.819 | Housing instability, housed unspecified | Problems related to housing and economic circumstances (Z59) |
| Z59.89 | Other problems related to housing and economic circumstances | Problems related to housing and economic circumstances (Z59) |
| Z59.9 | Problem related to housing and economic circumstances, unspecified | Problems related to housing and economic circumstances (Z59) |
| Z60.0 | Problems of adjustment to life-cycle transitions | Problems related to social environment (Z60) |
| Z60.2 | Problems related to living alone | Problems related to social environment (Z60) |
| Z60.3 | Acculturation difficulty | Problems related to social environment (Z60) |
| Z60.4 | Social exclusion and rejection | Problems related to social environment (Z60) |
| Z60.5 | Target of (perceived) adverse discrimination and persecution | Problems related to social environment (Z60) |
| Z60.8 | Other problems related to social environment | Problems related to social environment (Z60) |
| Z60.9 | Problem related to social environment, unspecified | Problems related to social environment (Z60) |
| Z62.0 | Inadequate parental supervision and control | Problems related to upbringing (Z62) |
| Z62.1 | Parental overprotection | Problems related to upbringing (Z62) |
| Z62.21 | Child in welfare custody | Problems related to upbringing (Z62) |
| Z62.22 | Institutional upbringing | Problems related to upbringing (Z62) |
| Z62.29 | Other upbringing away from parents | Problems related to upbringing (Z62) |
| Z62.3 | Hostility towards and scapegoating of child | Problems related to upbringing (Z62) |
| Z62.6 | Inappropriate (excessive) parental pressure | Problems related to upbringing (Z62) |
| Z62.810 | Personal history of physical and sexual abuse in childhood | Problems related to upbringing (Z62) |
| Z62.811 | Personal history of psychological abuse in childhood | Problems related to upbringing (Z62) |
| Z62.812 | Personal history of neglect in childhood | Problems related to upbringing (Z62) |
| Z62.813 | Personal history of forced labor or sexual exploitation in childhood | Problems related to upbringing (Z62) |
| Z62.819 | Personal history of unspecified abuse in childhood | Problems related to upbringing (Z62) |
| Z62.820 | Parent-biological child conflict | Problems related to upbringing (Z62) |
| Z62.821 | Parent-adopted child conflict | Problems related to upbringing (Z62) |
| Z62.822 | Parent-foster child conflict | Problems related to upbringing (Z62) |
| Z62.890 | Parent-child estrangement NEC | Problems related to upbringing (Z62) |
| Z62.891 | Sibling rivalry | Problems related to upbringing (Z62) |
| Z62.898 | Other specified problems related to upbringing | Problems related to upbringing (Z62) |
| Z62.9 | Problem related to upbringing, unspecified | Problems related to upbringing (Z62) |
| Z63.0 | Problems in relationship with spouse or partner | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.1 | Problems in relationship with in-laws | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.31 | Absence of family member due to military deployment | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.32 | Other absence of family member | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.4 | Disappearance and death of family member | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.5 | Disruption of family by separation and divorce | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.6 | Dependent relative needing care at home | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.71 | Stress on family due to return of family member from military deployment | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.72 | Alcoholism and drug addiction in family | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.79 | Other stressful life events affecting family and household | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.8 | Other specified problems related to primary support group | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z63.9 | Problem related to primary support group, unspecified | Oth prob rel to prim support group, inc family circumstances (Z63) |
| Z64.0 | Problems related to unwanted pregnancy | Problems related to certain psychosocial circumstances (Z64) |
| Z64.1 | Problems related to multiparity | Problems related to certain psychosocial circumstances (Z64) |
| Z64.4 | Discord with counselors | Problems related to certain psychosocial circumstances (Z64) |
| Z65.0 | Conviction in civil and criminal proceedings without imprisonment | Problems related to other psychosocial circumstances (Z65) |
| Z65.1 | Imprisonment and other incarceration | Problems related to other psychosocial circumstances (Z65) |
| Z65.2 | Problems related to release from prison | Problems related to other psychosocial circumstances (Z65) |
| Z65.3 | Problems related to other legal circumstances | Problems related to other psychosocial circumstances (Z65) |
| Z65.4 | Victim of crime and terrorism | Problems related to other psychosocial circumstances (Z65) |
| Z65.5 | Exposure to disaster, war and other hostilities | Problems related to other psychosocial circumstances (Z65) |
| Z65.8 | Other specified problems related to psychosocial circumstances | Problems related to other psychosocial circumstances (Z65) |
| Z65.9 | Problem related to unspecified psychosocial circumstances | Problems related to other psychosocial circumstances (Z65) |
| Z66 | Do not resuscitate | Do not resuscitate (Z66) |
| Z67.10 | Type A blood, Rh positive | Blood type (Z67) |
| Z67.11 | Type A blood, Rh negative | Blood type (Z67) |
| Z67.20 | Type B blood, Rh positive | Blood type (Z67) |
| Z67.21 | Type B blood, Rh negative | Blood type (Z67) |
| Z67.30 | Type AB blood, Rh positive | Blood type (Z67) |
| Z67.31 | Type AB blood, Rh negative | Blood type (Z67) |
| Z67.40 | Type O blood, Rh positive | Blood type (Z67) |
| Z67.41 | Type O blood, Rh negative | Blood type (Z67) |
| Z67.90 | Unspecified blood type, Rh positive | Blood type (Z67) |
| Z67.91 | Unspecified blood type, Rh negative | Blood type (Z67) |
| Z68.1 | Body mass index [BMI] 19.9 or less, adult | Body mass index [BMI] (Z68) |
| Z68.20 | Body mass index [BMI] 20.0-20.9, adult | Body mass index [BMI] (Z68) |
| Z68.21 | Body mass index [BMI] 21.0-21.9, adult | Body mass index [BMI] (Z68) |
| Z68.22 | Body mass index [BMI] 22.0-22.9, adult | Body mass index [BMI] (Z68) |
| Z68.23 | Body mass index [BMI] 23.0-23.9, adult | Body mass index [BMI] (Z68) |
| Z68.24 | Body mass index [BMI] 24.0-24.9, adult | Body mass index [BMI] (Z68) |
| Z68.25 | Body mass index [BMI] 25.0-25.9, adult | Body mass index [BMI] (Z68) |
| Z68.26 | Body mass index [BMI] 26.0-26.9, adult | Body mass index [BMI] (Z68) |
| Z68.27 | Body mass index [BMI] 27.0-27.9, adult | Body mass index [BMI] (Z68) |
| Z68.28 | Body mass index [BMI] 28.0-28.9, adult | Body mass index [BMI] (Z68) |
| Z68.29 | Body mass index [BMI] 29.0-29.9, adult | Body mass index [BMI] (Z68) |
| Z68.30 | Body mass index [BMI] 30.0-30.9, adult | Body mass index [BMI] (Z68) |
| Z68.31 | Body mass index [BMI] 31.0-31.9, adult | Body mass index [BMI] (Z68) |
| Z68.32 | Body mass index [BMI] 32.0-32.9, adult | Body mass index [BMI] (Z68) |
| Z68.33 | Body mass index [BMI] 33.0-33.9, adult | Body mass index [BMI] (Z68) |
| Z68.34 | Body mass index [BMI] 34.0-34.9, adult | Body mass index [BMI] (Z68) |
| Z68.35 | Body mass index [BMI] 35.0-35.9, adult | Body mass index [BMI] (Z68) |
| Z68.36 | Body mass index [BMI] 36.0-36.9, adult | Body mass index [BMI] (Z68) |
| Z68.37 | Body mass index [BMI] 37.0-37.9, adult | Body mass index [BMI] (Z68) |
| Z68.38 | Body mass index [BMI] 38.0-38.9, adult | Body mass index [BMI] (Z68) |
| Z68.39 | Body mass index [BMI] 39.0-39.9, adult | Body mass index [BMI] (Z68) |
| Z68.41 | Body mass index [BMI] 40.0-44.9, adult | Body mass index [BMI] (Z68) |
| Z68.42 | Body mass index [BMI] 45.0-49.9, adult | Body mass index [BMI] (Z68) |
| Z68.43 | Body mass index [BMI] 50.0-59.9, adult | Body mass index [BMI] (Z68) |
| Z68.44 | Body mass index [BMI] 60.0-69.9, adult | Body mass index [BMI] (Z68) |
| Z68.45 | Body mass index [BMI] 70 or greater, adult | Body mass index [BMI] (Z68) |
| Z68.51 | Body mass index [BMI] pediatric, less than 5th percentile for age | Body mass index [BMI] (Z68) |
| Z68.52 | Body mass index [BMI] pediatric, 5th percentile to less than 85th percentile for age | Body mass index [BMI] (Z68) |
| Z68.53 | Body mass index [BMI] pediatric, 85th percentile to less than 95th percentile for age | Body mass index [BMI] (Z68) |
| Z68.54 | Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age | Body mass index [BMI] (Z68) |
| Z69.011 | Encounter for mental health services for perpetrator of parental child abuse | Encntr for mental health serv for victim and perp of abuse (Z69) |
| Z69.021 | Encounter for mental health services for perpetrator of non-parental child abuse | Encntr for mental health serv for victim and perp of abuse (Z69) |
| Z69.11 | Encounter for mental health services for victim of spousal or partner abuse | Encntr for mental health serv for victim and perp of abuse (Z69) |
| Z69.12 | Encounter for mental health services for perpetrator of spousal or partner abuse | Encntr for mental health serv for victim and perp of abuse (Z69) |
| Z69.81 | Encounter for mental health services for victim of other abuse | Encntr for mental health serv for victim and perp of abuse (Z69) |
| Z69.82 | Encounter for mental health services for perpetrator of other abuse | Encntr for mental health serv for victim and perp of abuse (Z69) |
| Z70.0 | Counseling related to sexual attitude | Counseling related to sexual attitude, behavior and orientn (Z70) |
| Z70.1 | Counseling related to patient's sexual behavior and orientation | Counseling related to sexual attitude, behavior and orientn (Z70) |
| Z70.2 | Counseling related to sexual behavior and orientation of third party | Counseling related to sexual attitude, behavior and orientn (Z70) |
| Z70.3 | Counseling related to combined concerns regarding sexual attitude, behavior and orientation | Counseling related to sexual attitude, behavior and orientn (Z70) |
| Z70.8 | Other sex counseling | Counseling related to sexual attitude, behavior and orientn (Z70) |
| Z70.9 | Sex counseling, unspecified | Counseling related to sexual attitude, behavior and orientn (Z70) |
| Z71.0 | Person encountering health services to consult on behalf of another person | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.1 | Person with feared health complaint in whom no diagnosis is made | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.2 | Person consulting for explanation of examination or test findings | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.3 | Dietary counseling and surveillance | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.41 | Alcohol abuse counseling and surveillance of alcoholic | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.42 | Counseling for family member of alcoholic | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.51 | Drug abuse counseling and surveillance of drug abuser | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.52 | Counseling for family member of drug abuser | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.6 | Tobacco abuse counseling | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.7 | Human immunodeficiency virus [HIV] counseling | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.81 | Spiritual or religious counseling | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.82 | Exercise counseling | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.84 | Encounter for health counseling related to travel | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.85 | Encounter for immunization safety counseling | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.89 | Other specified counseling | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z71.9 | Counseling, unspecified | Persons encntr health serv for oth cnsl and med advice, NEC (Z71) |
| Z72.0 | Tobacco use | Problems related to lifestyle (Z72) |
| Z72.3 | Lack of physical exercise | Problems related to lifestyle (Z72) |
| Z72.4 | Inappropriate diet and eating habits | Problems related to lifestyle (Z72) |
| Z72.51 | High risk heterosexual behavior | Problems related to lifestyle (Z72) |
| Z72.52 | High risk homosexual behavior | Problems related to lifestyle (Z72) |
| Z72.53 | High risk bisexual behavior | Problems related to lifestyle (Z72) |
| Z72.6 | Gambling and betting | Problems related to lifestyle (Z72) |
| Z72.821 | Inadequate sleep hygiene | Problems related to lifestyle (Z72) |
| Z72.89 | Other problems related to lifestyle | Problems related to lifestyle (Z72) |
| Z72.9 | Problem related to lifestyle, unspecified | Problems related to lifestyle (Z72) |
| Z73.0 | Burn-out | Problems related to life management difficulty (Z73) |
| Z73.1 | Type A behavior pattern | Problems related to life management difficulty (Z73) |
| Z73.2 | Lack of relaxation and leisure | Problems related to life management difficulty (Z73) |
| Z73.3 | Stress, not elsewhere classified | Problems related to life management difficulty (Z73) |
| Z73.4 | Inadequate social skills, not elsewhere classified | Problems related to life management difficulty (Z73) |
| Z73.5 | Social role conflict, not elsewhere classified | Problems related to life management difficulty (Z73) |
| Z73.6 | Limitation of activities due to disability | Problems related to life management difficulty (Z73) |
| Z73.810 | Behavioral insomnia of childhood, sleep-onset association type | Problems related to life management difficulty (Z73) |
| Z73.811 | Behavioral insomnia of childhood, limit setting type | Problems related to life management difficulty (Z73) |
| Z73.812 | Behavioral insomnia of childhood, combined type | Problems related to life management difficulty (Z73) |
| Z73.819 | Behavioral insomnia of childhood, unspecified type | Problems related to life management difficulty (Z73) |
| Z73.82 | Dual sensory impairment | Problems related to life management difficulty (Z73) |
| Z73.89 | Other problems related to life management difficulty | Problems related to life management difficulty (Z73) |
| Z73.9 | Problem related to life management difficulty, unspecified | Problems related to life management difficulty (Z73) |
| Z74.01 | Bed confinement status | Problems related to care provider dependency (Z74) |
| Z74.09 | Other reduced mobility | Problems related to care provider dependency (Z74) |
| Z74.1 | Need for assistance with personal care | Problems related to care provider dependency (Z74) |
| Z74.2 | Need for assistance at home and no other household member able to render care | Problems related to care provider dependency (Z74) |
| Z74.3 | Need for continuous supervision | Problems related to care provider dependency (Z74) |
| Z74.8 | Other problems related to care provider dependency | Problems related to care provider dependency (Z74) |
| Z74.9 | Problem related to care provider dependency, unspecified | Problems related to care provider dependency (Z74) |
| Z75.0 | Medical services not available in home | Problems related to medical facilities and other health care (Z75) |
| Z75.1 | Person awaiting admission to adequate facility elsewhere | Problems related to medical facilities and other health care (Z75) |
| Z75.2 | Other waiting period for investigation and treatment | Problems related to medical facilities and other health care (Z75) |
| Z75.3 | Unavailability and inaccessibility of health-care facilities | Problems related to medical facilities and other health care (Z75) |
| Z75.4 | Unavailability and inaccessibility of other helping agencies | Problems related to medical facilities and other health care (Z75) |
| Z75.5 | Holiday relief care | Problems related to medical facilities and other health care (Z75) |
| Z75.8 | Other problems related to medical facilities and other health care | Problems related to medical facilities and other health care (Z75) |
| Z75.9 | Unspecified problem related to medical facilities and other health care | Problems related to medical facilities and other health care (Z75) |
| Z76.0 | Encounter for issue of repeat prescription | Persons encountering health services in other circumstances (Z76) |
| Z76.2 | Encounter for health supervision and care of other healthy infant and child | Persons encountering health services in other circumstances (Z76) |
| Z76.81 | Expectant parent(s) prebirth pediatrician visit | Persons encountering health services in other circumstances (Z76) |
| Z76.82 | Awaiting organ transplant status | Persons encountering health services in other circumstances (Z76) |
| Z76.89 | Persons encountering health services in other specified circumstances | Persons encountering health services in other circumstances (Z76) |
| Z77.010 | Contact with and (suspected) exposure to arsenic | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.011 | Contact with and (suspected) exposure to lead | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.012 | Contact with and (suspected) exposure to uranium | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.018 | Contact with and (suspected) exposure to other hazardous metals | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.020 | Contact with and (suspected) exposure to aromatic amines | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.021 | Contact with and (suspected) exposure to benzene | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.028 | Contact with and (suspected) exposure to other hazardous aromatic compounds | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.090 | Contact with and (suspected) exposure to asbestos | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.098 | Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.110 | Contact with and (suspected) exposure to air pollution | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.111 | Contact with and (suspected) exposure to water pollution | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.112 | Contact with and (suspected) exposure to soil pollution | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.118 | Contact with and (suspected) exposure to other environmental pollution | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.120 | Contact with and (suspected) exposure to mold (toxic) | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.121 | Contact with and (suspected) exposure to harmful algae and algae toxins | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.122 | Contact with and (suspected) exposure to noise | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.123 | Contact with and (suspected) exposure to radon and other naturally occurring radiation | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.128 | Contact with and (suspected) exposure to other hazards in the physical environment | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.21 | Contact with and (suspected) exposure to potentially hazardous body fluids | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.22 | Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.29 | Contact with and (suspected) exposure to other hazardous substances | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z77.9 | Other contact with and (suspected) exposures hazardous to health | Oth contact w and (suspected) exposures hazardous to health (Z77) |
| Z78.0 | Asymptomatic menopausal state | Other specified health status (Z78) |
| Z78.1 | Physical restraint status | Other specified health status (Z78) |
| Z78.9 | Other specified health status | Other specified health status (Z78) |
| Z79.02 | Long term (current) use of antithrombotics/antiplatelets | Long term (current) drug therapy (Z79) |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) | Long term (current) drug therapy (Z79) |
| Z79.2 | Long term (current) use of antibiotics | Long term (current) drug therapy (Z79) |
| Z79.51 | Long term (current) use of inhaled steroids | Long term (current) drug therapy (Z79) |
| Z79.52 | Long term (current) use of systemic steroids | Long term (current) drug therapy (Z79) |
| Z79.810 | Long term (current) use of selective estrogen receptor modulators (SERMs) | Long term (current) drug therapy (Z79) |
| Z79.811 | Long term (current) use of aromatase inhibitors | Long term (current) drug therapy (Z79) |
| Z79.818 | Long term (current) use of other agents affecting estrogen receptors and estrogen levels | Long term (current) drug therapy (Z79) |
| Z79.83 | Long term (current) use of bisphosphonates | Long term (current) drug therapy (Z79) |
| Z79.84 | Long term (current) use of oral hypoglycemic drugs | Long term (current) drug therapy (Z79) |
| Z79.890 | Hormone replacement therapy | Long term (current) drug therapy (Z79) |
| Z80.0 | Family history of malignant neoplasm of digestive organs | Family history of primary malignant neoplasm (Z80) |
| Z80.1 | Family history of malignant neoplasm of trachea, bronchus and lung | Family history of primary malignant neoplasm (Z80) |
| Z80.2 | Family history of malignant neoplasm of other respiratory and intrathoracic organs | Family history of primary malignant neoplasm (Z80) |
| Z80.3 | Family history of malignant neoplasm of breast | Family history of primary malignant neoplasm (Z80) |
| Z80.41 | Family history of malignant neoplasm of ovary | Family history of primary malignant neoplasm (Z80) |
| Z80.42 | Family history of malignant neoplasm of prostate | Family history of primary malignant neoplasm (Z80) |
| Z80.43 | Family history of malignant neoplasm of testis | Family history of primary malignant neoplasm (Z80) |
| Z80.49 | Family history of malignant neoplasm of other genital organs | Family history of primary malignant neoplasm (Z80) |
| Z80.51 | Family history of malignant neoplasm of kidney | Family history of primary malignant neoplasm (Z80) |
| Z80.52 | Family history of malignant neoplasm of bladder | Family history of primary malignant neoplasm (Z80) |
| Z80.59 | Family history of malignant neoplasm of other urinary tract organ | Family history of primary malignant neoplasm (Z80) |
| Z80.6 | Family history of leukemia | Family history of primary malignant neoplasm (Z80) |
| Z80.7 | Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues | Family history of primary malignant neoplasm (Z80) |
| Z80.8 | Family history of malignant neoplasm of other organs or systems | Family history of primary malignant neoplasm (Z80) |
| Z80.9 | Family history of malignant neoplasm, unspecified | Family history of primary malignant neoplasm (Z80) |
| Z81.0 | Family history of intellectual disabilities | Family history of mental and behavioral disorders (Z81) |
| Z81.1 | Family history of alcohol abuse and dependence | Family history of mental and behavioral disorders (Z81) |
| Z81.2 | Family history of tobacco abuse and dependence | Family history of mental and behavioral disorders (Z81) |
| Z81.3 | Family history of other psychoactive substance abuse and dependence | Family history of mental and behavioral disorders (Z81) |
| Z81.4 | Family history of other substance abuse and dependence | Family history of mental and behavioral disorders (Z81) |
| Z81.8 | Family history of other mental and behavioral disorders | Family history of mental and behavioral disorders (Z81) |
| Z82.0 | Family history of epilepsy and other diseases of the nervous system | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.1 | Family history of blindness and visual loss | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.2 | Family history of deafness and hearing loss | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.3 | Family history of stroke | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.41 | Family history of sudden cardiac death | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.49 | Family history of ischemic heart disease and other diseases of the circulatory system | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.5 | Family history of asthma and other chronic lower respiratory diseases | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.61 | Family history of arthritis | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.62 | Family history of osteoporosis | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.69 | Family history of other diseases of the musculoskeletal system and connective tissue | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.71 | Family history of polycystic kidney | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.79 | Family history of other congenital malformations, deformations and chromosomal abnormalities | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z82.8 | Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified | Fam hx of certain disabil & chr dis (leading to disablement) (Z82) |
| Z83.0 | Family history of human immunodeficiency virus [HIV] disease | Family history of other specific disorders (Z83) |
| Z83.1 | Family history of other infectious and parasitic diseases | Family history of other specific disorders (Z83) |
| Z83.2 | Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Family history of other specific disorders (Z83) |
| Z83.3 | Family history of diabetes mellitus | Family history of other specific disorders (Z83) |
| Z83.41 | Family history of multiple endocrine neoplasia [MEN] syndrome | Family history of other specific disorders (Z83) |
| Z83.42 | Family history of familial hypercholesterolemia | Family history of other specific disorders (Z83) |
| Z83.430 | Family history of elevated lipoprotein(a) | Family history of other specific disorders (Z83) |
| Z83.438 | Family history of other disorder of lipoprotein metabolism and other lipidemia | Family history of other specific disorders (Z83) |
| Z83.49 | Family history of other endocrine, nutritional and metabolic diseases | Family history of other specific disorders (Z83) |
| Z83.511 | Family history of glaucoma | Family history of other specific disorders (Z83) |
| Z83.518 | Family history of other specified eye disorder | Family history of other specific disorders (Z83) |
| Z83.52 | Family history of ear disorders | Family history of other specific disorders (Z83) |
| Z83.6 | Family history of other diseases of the respiratory system | Family history of other specific disorders (Z83) |
| Z83.71 | Family history of colonic polyps | Family history of other specific disorders (Z83) |
| Z83.79 | Family history of other diseases of the digestive system | Family history of other specific disorders (Z83) |
| Z84.0 | Family history of diseases of the skin and subcutaneous tissue | Family history of other conditions (Z84) |
| Z84.1 | Family history of disorders of kidney and ureter | Family history of other conditions (Z84) |
| Z84.2 | Family history of other diseases of the genitourinary system | Family history of other conditions (Z84) |
| Z84.3 | Family history of consanguinity | Family history of other conditions (Z84) |
| Z84.81 | Family history of carrier of genetic disease | Family history of other conditions (Z84) |
| Z84.82 | Family history of sudden infant death syndrome | Family history of other conditions (Z84) |
| Z84.89 | Family history of other specified conditions | Family history of other conditions (Z84) |
| Z85.00 | Personal history of malignant neoplasm of unspecified digestive organ | Personal history of malignant neoplasm (Z85) |
| Z85.01 | Personal history of malignant neoplasm of esophagus | Personal history of malignant neoplasm (Z85) |
| Z85.020 | Personal history of malignant carcinoid tumor of stomach | Personal history of malignant neoplasm (Z85) |
| Z85.028 | Personal history of other malignant neoplasm of stomach | Personal history of malignant neoplasm (Z85) |
| Z85.030 | Personal history of malignant carcinoid tumor of large intestine | Personal history of malignant neoplasm (Z85) |
| Z85.038 | Personal history of other malignant neoplasm of large intestine | Personal history of malignant neoplasm (Z85) |
| Z85.040 | Personal history of malignant carcinoid tumor of rectum | Personal history of malignant neoplasm (Z85) |
| Z85.048 | Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus | Personal history of malignant neoplasm (Z85) |
| Z85.05 | Personal history of malignant neoplasm of liver | Personal history of malignant neoplasm (Z85) |
| Z85.060 | Personal history of malignant carcinoid tumor of small intestine | Personal history of malignant neoplasm (Z85) |
| Z85.068 | Personal history of other malignant neoplasm of small intestine | Personal history of malignant neoplasm (Z85) |
| Z85.07 | Personal history of malignant neoplasm of pancreas | Personal history of malignant neoplasm (Z85) |
| Z85.09 | Personal history of malignant neoplasm of other digestive organs | Personal history of malignant neoplasm (Z85) |
| Z85.110 | Personal history of malignant carcinoid tumor of bronchus and lung | Personal history of malignant neoplasm (Z85) |
| Z85.118 | Personal history of other malignant neoplasm of bronchus and lung | Personal history of malignant neoplasm (Z85) |
| Z85.12 | Personal history of malignant neoplasm of trachea | Personal history of malignant neoplasm (Z85) |
| Z85.20 | Personal history of malignant neoplasm of unspecified respiratory organ | Personal history of malignant neoplasm (Z85) |
| Z85.21 | Personal history of malignant neoplasm of larynx | Personal history of malignant neoplasm (Z85) |
| Z85.22 | Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses | Personal history of malignant neoplasm (Z85) |
| Z85.230 | Personal history of malignant carcinoid tumor of thymus | Personal history of malignant neoplasm (Z85) |
| Z85.238 | Personal history of other malignant neoplasm of thymus | Personal history of malignant neoplasm (Z85) |
| Z85.29 | Personal history of malignant neoplasm of other respiratory and intrathoracic organs | Personal history of malignant neoplasm (Z85) |
| Z85.3 | Personal history of malignant neoplasm of breast | Personal history of malignant neoplasm (Z85) |
| Z85.40 | Personal history of malignant neoplasm of unspecified female genital organ | Personal history of malignant neoplasm (Z85) |
| Z85.41 | Personal history of malignant neoplasm of cervix uteri | Personal history of malignant neoplasm (Z85) |
| Z85.42 | Personal history of malignant neoplasm of other parts of uterus | Personal history of malignant neoplasm (Z85) |
| Z85.43 | Personal history of malignant neoplasm of ovary | Personal history of malignant neoplasm (Z85) |
| Z85.44 | Personal history of malignant neoplasm of other female genital organs | Personal history of malignant neoplasm (Z85) |
| Z85.45 | Personal history of malignant neoplasm of unspecified male genital organ | Personal history of malignant neoplasm (Z85) |
| Z85.46 | Personal history of malignant neoplasm of prostate | Personal history of malignant neoplasm (Z85) |
| Z85.47 | Personal history of malignant neoplasm of testis | Personal history of malignant neoplasm (Z85) |
| Z85.48 | Personal history of malignant neoplasm of epididymis | Personal history of malignant neoplasm (Z85) |
| Z85.49 | Personal history of malignant neoplasm of other male genital organs | Personal history of malignant neoplasm (Z85) |
| Z85.50 | Personal history of malignant neoplasm of unspecified urinary tract organ | Personal history of malignant neoplasm (Z85) |
| Z85.51 | Personal history of malignant neoplasm of bladder | Personal history of malignant neoplasm (Z85) |
| Z85.520 | Personal history of malignant carcinoid tumor of kidney | Personal history of malignant neoplasm (Z85) |
| Z85.528 | Personal history of other malignant neoplasm of kidney | Personal history of malignant neoplasm (Z85) |
| Z85.53 | Personal history of malignant neoplasm of renal pelvis | Personal history of malignant neoplasm (Z85) |
| Z85.54 | Personal history of malignant neoplasm of ureter | Personal history of malignant neoplasm (Z85) |
| Z85.59 | Personal history of malignant neoplasm of other urinary tract organ | Personal history of malignant neoplasm (Z85) |
| Z85.6 | Personal history of leukemia | Personal history of malignant neoplasm (Z85) |
| Z85.71 | Personal history of Hodgkin lymphoma | Personal history of malignant neoplasm (Z85) |
| Z85.72 | Personal history of non-Hodgkin lymphomas | Personal history of malignant neoplasm (Z85) |
| Z85.79 | Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues | Personal history of malignant neoplasm (Z85) |
| Z85.810 | Personal history of malignant neoplasm of tongue | Personal history of malignant neoplasm (Z85) |
| Z85.818 | Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx | Personal history of malignant neoplasm (Z85) |
| Z85.819 | Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx | Personal history of malignant neoplasm (Z85) |
| Z85.820 | Personal history of malignant melanoma of skin | Personal history of malignant neoplasm (Z85) |
| Z85.821 | Personal history of Merkel cell carcinoma | Personal history of malignant neoplasm (Z85) |
| Z85.828 | Personal history of other malignant neoplasm of skin | Personal history of malignant neoplasm (Z85) |
| Z85.830 | Personal history of malignant neoplasm of bone | Personal history of malignant neoplasm (Z85) |
| Z85.831 | Personal history of malignant neoplasm of soft tissue | Personal history of malignant neoplasm (Z85) |
| Z85.840 | Personal history of malignant neoplasm of eye | Personal history of malignant neoplasm (Z85) |
| Z85.841 | Personal history of malignant neoplasm of brain | Personal history of malignant neoplasm (Z85) |
| Z85.848 | Personal history of malignant neoplasm of other parts of nervous tissue | Personal history of malignant neoplasm (Z85) |
| Z85.850 | Personal history of malignant neoplasm of thyroid | Personal history of malignant neoplasm (Z85) |
| Z85.858 | Personal history of malignant neoplasm of other endocrine glands | Personal history of malignant neoplasm (Z85) |
| Z85.89 | Personal history of malignant neoplasm of other organs and systems | Personal history of malignant neoplasm (Z85) |
| Z85.9 | Personal history of malignant neoplasm, unspecified | Personal history of malignant neoplasm (Z85) |
| Z86.000 | Personal history of in-situ neoplasm of breast | Personal history of certain other diseases (Z86) |
| Z86.001 | Personal history of in-situ neoplasm of cervix uteri | Personal history of certain other diseases (Z86) |
| Z86.002 | Personal history of in-situ neoplasm of other and unspecified genital organs | Personal history of certain other diseases (Z86) |
| Z86.003 | Personal history of in-situ neoplasm of oral cavity, esophagus and stomach | Personal history of certain other diseases (Z86) |
| Z86.004 | Personal history of in-situ neoplasm of other and unspecified digestive organs | Personal history of certain other diseases (Z86) |
| Z86.005 | Personal history of in-situ neoplasm of middle ear and respiratory system | Personal history of certain other diseases (Z86) |
| Z86.006 | Personal history of melanoma in-situ | Personal history of certain other diseases (Z86) |
| Z86.007 | Personal history of in-situ neoplasm of skin | Personal history of certain other diseases (Z86) |
| Z86.008 | Personal history of in-situ neoplasm of other site | Personal history of certain other diseases (Z86) |
| Z86.010 | Personal history of colonic polyps | Personal history of certain other diseases (Z86) |
| Z86.011 | Personal history of benign neoplasm of the brain | Personal history of certain other diseases (Z86) |
| Z86.012 | Personal history of benign carcinoid tumor | Personal history of certain other diseases (Z86) |
| Z86.018 | Personal history of other benign neoplasm | Personal history of certain other diseases (Z86) |
| Z86.03 | Personal history of neoplasm of uncertain behavior | Personal history of certain other diseases (Z86) |
| Z86.11 | Personal history of tuberculosis | Personal history of certain other diseases (Z86) |
| Z86.12 | Personal history of poliomyelitis | Personal history of certain other diseases (Z86) |
| Z86.13 | Personal history of malaria | Personal history of certain other diseases (Z86) |
| Z86.14 | Personal history of Methicillin resistant Staphylococcus aureus infection | Personal history of certain other diseases (Z86) |
| Z86.15 | Personal history of latent tuberculosis infection | Personal history of certain other diseases (Z86) |
| Z86.16 | Personal history of COVID-19 | Personal history of certain other diseases (Z86) |
| Z86.19 | Personal history of other infectious and parasitic diseases | Personal history of certain other diseases (Z86) |
| Z86.2 | Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Personal history of certain other diseases (Z86) |
| Z86.31 | Personal history of diabetic foot ulcer | Personal history of certain other diseases (Z86) |
| Z86.32 | Personal history of gestational diabetes | Personal history of certain other diseases (Z86) |
| Z86.39 | Personal history of other endocrine, nutritional and metabolic disease | Personal history of certain other diseases (Z86) |
| Z86.51 | Personal history of combat and operational stress reaction | Personal history of certain other diseases (Z86) |
| Z86.59 | Personal history of other mental and behavioral disorders | Personal history of certain other diseases (Z86) |
| Z86.61 | Personal history of infections of the central nervous system | Personal history of certain other diseases (Z86) |
| Z86.69 | Personal history of other diseases of the nervous system and sense organs | Personal history of certain other diseases (Z86) |
| Z86.711 | Personal history of pulmonary embolism | Personal history of certain other diseases (Z86) |
| Z86.718 | Personal history of other venous thrombosis and embolism | Personal history of certain other diseases (Z86) |
| Z86.72 | Personal history of thrombophlebitis | Personal history of certain other diseases (Z86) |
| Z86.73 | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits | Personal history of certain other diseases (Z86) |
| Z86.74 | Personal history of sudden cardiac arrest | Personal history of certain other diseases (Z86) |
| Z86.79 | Personal history of other diseases of the circulatory system | Personal history of certain other diseases (Z86) |
| Z87.01 | Personal history of pneumonia (recurrent) | Personal history of other diseases and conditions (Z87) |
| Z87.09 | Personal history of other diseases of the respiratory system | Personal history of other diseases and conditions (Z87) |
| Z87.11 | Personal history of peptic ulcer disease | Personal history of other diseases and conditions (Z87) |
| Z87.19 | Personal history of other diseases of the digestive system | Personal history of other diseases and conditions (Z87) |
| Z87.2 | Personal history of diseases of the skin and subcutaneous tissue | Personal history of other diseases and conditions (Z87) |
| Z87.310 | Personal history of (healed) osteoporosis fracture | Personal history of other diseases and conditions (Z87) |
| Z87.311 | Personal history of (healed) other pathological fracture | Personal history of other diseases and conditions (Z87) |
| Z87.312 | Personal history of (healed) stress fracture | Personal history of other diseases and conditions (Z87) |
| Z87.39 | Personal history of other diseases of the musculoskeletal system and connective tissue | Personal history of other diseases and conditions (Z87) |
| Z87.410 | Personal history of cervical dysplasia | Personal history of other diseases and conditions (Z87) |
| Z87.411 | Personal history of vaginal dysplasia | Personal history of other diseases and conditions (Z87) |
| Z87.412 | Personal history of vulvar dysplasia | Personal history of other diseases and conditions (Z87) |
| Z87.42 | Personal history of other diseases of the female genital tract | Personal history of other diseases and conditions (Z87) |
| Z87.430 | Personal history of prostatic dysplasia | Personal history of other diseases and conditions (Z87) |
| Z87.438 | Personal history of other diseases of male genital organs | Personal history of other diseases and conditions (Z87) |
| Z87.440 | Personal history of urinary (tract) infections | Personal history of other diseases and conditions (Z87) |
| Z87.441 | Personal history of nephrotic syndrome | Personal history of other diseases and conditions (Z87) |
| Z87.442 | Personal history of urinary calculi | Personal history of other diseases and conditions (Z87) |
| Z87.448 | Personal history of other diseases of urinary system | Personal history of other diseases and conditions (Z87) |
| Z87.51 | Personal history of pre-term labor | Personal history of other diseases and conditions (Z87) |
| Z87.59 | Personal history of other complications of pregnancy, childbirth and the puerperium | Personal history of other diseases and conditions (Z87) |
| Z87.710 | Personal history of (corrected) hypospadias | Personal history of other diseases and conditions (Z87) |
| Z87.718 | Personal history of other specified (corrected) congenital malformations of genitourinary system | Personal history of other diseases and conditions (Z87) |
| Z87.720 | Personal history of (corrected) congenital malformations of eye | Personal history of other diseases and conditions (Z87) |
| Z87.721 | Personal history of (corrected) congenital malformations of ear | Personal history of other diseases and conditions (Z87) |
| Z87.728 | Personal history of other specified (corrected) congenital malformations of nervous system and sense organs | Personal history of other diseases and conditions (Z87) |
| Z87.730 | Personal history of (corrected) cleft lip and palate | Personal history of other diseases and conditions (Z87) |
| Z87.738 | Personal history of other specified (corrected) congenital malformations of digestive system | Personal history of other diseases and conditions (Z87) |
| Z87.74 | Personal history of (corrected) congenital malformations of heart and circulatory system | Personal history of other diseases and conditions (Z87) |
| Z87.75 | Personal history of (corrected) congenital malformations of respiratory system | Personal history of other diseases and conditions (Z87) |
| Z87.76 | Personal history of (corrected) congenital malformations of integument, limbs and musculoskeletal system | Personal history of other diseases and conditions (Z87) |
| Z87.790 | Personal history of (corrected) congenital malformations of face and neck | Personal history of other diseases and conditions (Z87) |
| Z87.798 | Personal history of other (corrected) congenital malformations | Personal history of other diseases and conditions (Z87) |
| Z87.81 | Personal history of (healed) traumatic fracture | Personal history of other diseases and conditions (Z87) |
| Z87.820 | Personal history of traumatic brain injury | Personal history of other diseases and conditions (Z87) |
| Z87.821 | Personal history of retained foreign body fully removed | Personal history of other diseases and conditions (Z87) |
| Z87.828 | Personal history of other (healed) physical injury and trauma | Personal history of other diseases and conditions (Z87) |
| Z87.891 | Personal history of nicotine dependence | Personal history of other diseases and conditions (Z87) |
| Z87.892 | Personal history of anaphylaxis | Personal history of other diseases and conditions (Z87) |
| Z87.898 | Personal history of other specified conditions | Personal history of other diseases and conditions (Z87) |
| Z88.0 | Allergy status to penicillin | Allergy status to drug/meds/biol subst (Z88) |
| Z88.1 | Allergy status to other antibiotic agents | Allergy status to drug/meds/biol subst (Z88) |
| Z88.2 | Allergy status to sulfonamides | Allergy status to drug/meds/biol subst (Z88) |
| Z88.3 | Allergy status to other anti-infective agents | Allergy status to drug/meds/biol subst (Z88) |
| Z88.4 | Allergy status to anesthetic agent | Allergy status to drug/meds/biol subst (Z88) |
| Z88.5 | Allergy status to narcotic agent | Allergy status to drug/meds/biol subst (Z88) |
| Z88.6 | Allergy status to analgesic agent | Allergy status to drug/meds/biol subst (Z88) |
| Z88.7 | Allergy status to serum and vaccine | Allergy status to drug/meds/biol subst (Z88) |
| Z88.8 | Allergy status to other drugs, medicaments and biological substances | Allergy status to drug/meds/biol subst (Z88) |
| Z88.9 | Allergy status to unspecified drugs, medicaments and biological substances | Allergy status to drug/meds/biol subst (Z88) |
| Z89.011 | Acquired absence of right thumb | Acquired absence of limb (Z89) |
| Z89.012 | Acquired absence of left thumb | Acquired absence of limb (Z89) |
| Z89.019 | Acquired absence of unspecified thumb | Acquired absence of limb (Z89) |
| Z89.021 | Acquired absence of right finger(s) | Acquired absence of limb (Z89) |
| Z89.022 | Acquired absence of left finger(s) | Acquired absence of limb (Z89) |
| Z89.029 | Acquired absence of unspecified finger(s) | Acquired absence of limb (Z89) |
| Z89.111 | Acquired absence of right hand | Acquired absence of limb (Z89) |
| Z89.112 | Acquired absence of left hand | Acquired absence of limb (Z89) |
| Z89.119 | Acquired absence of unspecified hand | Acquired absence of limb (Z89) |
| Z89.121 | Acquired absence of right wrist | Acquired absence of limb (Z89) |
| Z89.122 | Acquired absence of left wrist | Acquired absence of limb (Z89) |
| Z89.129 | Acquired absence of unspecified wrist | Acquired absence of limb (Z89) |
| Z89.201 | Acquired absence of right upper limb, unspecified level | Acquired absence of limb (Z89) |
| Z89.202 | Acquired absence of left upper limb, unspecified level | Acquired absence of limb (Z89) |
| Z89.209 | Acquired absence of unspecified upper limb, unspecified level | Acquired absence of limb (Z89) |
| Z89.211 | Acquired absence of right upper limb below elbow | Acquired absence of limb (Z89) |
| Z89.212 | Acquired absence of left upper limb below elbow | Acquired absence of limb (Z89) |
| Z89.219 | Acquired absence of unspecified upper limb below elbow | Acquired absence of limb (Z89) |
| Z89.221 | Acquired absence of right upper limb above elbow | Acquired absence of limb (Z89) |
| Z89.222 | Acquired absence of left upper limb above elbow | Acquired absence of limb (Z89) |
| Z89.229 | Acquired absence of unspecified upper limb above elbow | Acquired absence of limb (Z89) |
| Z89.231 | Acquired absence of right shoulder | Acquired absence of limb (Z89) |
| Z89.232 | Acquired absence of left shoulder | Acquired absence of limb (Z89) |
| Z89.239 | Acquired absence of unspecified shoulder | Acquired absence of limb (Z89) |
| Z89.411 | Acquired absence of right great toe | Acquired absence of limb (Z89) |
| Z89.412 | Acquired absence of left great toe | Acquired absence of limb (Z89) |
| Z89.419 | Acquired absence of unspecified great toe | Acquired absence of limb (Z89) |
| Z89.421 | Acquired absence of other right toe(s) | Acquired absence of limb (Z89) |
| Z89.422 | Acquired absence of other left toe(s) | Acquired absence of limb (Z89) |
| Z89.429 | Acquired absence of other toe(s), unspecified side | Acquired absence of limb (Z89) |
| Z89.431 | Acquired absence of right foot | Acquired absence of limb (Z89) |
| Z89.432 | Acquired absence of left foot | Acquired absence of limb (Z89) |
| Z89.439 | Acquired absence of unspecified foot | Acquired absence of limb (Z89) |
| Z89.441 | Acquired absence of right ankle | Acquired absence of limb (Z89) |
| Z89.442 | Acquired absence of left ankle | Acquired absence of limb (Z89) |
| Z89.449 | Acquired absence of unspecified ankle | Acquired absence of limb (Z89) |
| Z89.511 | Acquired absence of right leg below knee | Acquired absence of limb (Z89) |
| Z89.512 | Acquired absence of left leg below knee | Acquired absence of limb (Z89) |
| Z89.519 | Acquired absence of unspecified leg below knee | Acquired absence of limb (Z89) |
| Z89.521 | Acquired absence of right knee | Acquired absence of limb (Z89) |
| Z89.522 | Acquired absence of left knee | Acquired absence of limb (Z89) |
| Z89.529 | Acquired absence of unspecified knee | Acquired absence of limb (Z89) |
| Z89.611 | Acquired absence of right leg above knee | Acquired absence of limb (Z89) |
| Z89.612 | Acquired absence of left leg above knee | Acquired absence of limb (Z89) |
| Z89.619 | Acquired absence of unspecified leg above knee | Acquired absence of limb (Z89) |
| Z89.621 | Acquired absence of right hip joint | Acquired absence of limb (Z89) |
| Z89.622 | Acquired absence of left hip joint | Acquired absence of limb (Z89) |
| Z89.629 | Acquired absence of unspecified hip joint | Acquired absence of limb (Z89) |
| Z89.9 | Acquired absence of limb, unspecified | Acquired absence of limb (Z89) |
| Z90.01 | Acquired absence of eye | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.02 | Acquired absence of larynx | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.09 | Acquired absence of other part of head and neck | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.2 | Acquired absence of lung [part of] | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.3 | Acquired absence of stomach [part of] | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.410 | Acquired total absence of pancreas | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.411 | Acquired partial absence of pancreas | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.49 | Acquired absence of other specified parts of digestive tract | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.5 | Acquired absence of kidney | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.6 | Acquired absence of other parts of urinary tract | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.710 | Acquired absence of both cervix and uterus | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.711 | Acquired absence of uterus with remaining cervical stump | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.712 | Acquired absence of cervix with remaining uterus | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.721 | Acquired absence of ovaries, unilateral | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.722 | Acquired absence of ovaries, bilateral | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.79 | Acquired absence of other genital organ(s) | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.81 | Acquired absence of spleen | Acquired absence of organs, not elsewhere classified (Z90) |
| Z90.89 | Acquired absence of other organs | Acquired absence of organs, not elsewhere classified (Z90) |
| Z91.010 | Allergy to peanuts | Personal risk factors, not elsewhere classified (Z91) |
| Z91.011 | Allergy to milk products | Personal risk factors, not elsewhere classified (Z91) |
| Z91.012 | Allergy to eggs | Personal risk factors, not elsewhere classified (Z91) |
| Z91.013 | Allergy to seafood | Personal risk factors, not elsewhere classified (Z91) |
| Z91.014 | Allergy to mammalian meats | Personal risk factors, not elsewhere classified (Z91) |
| Z91.018 | Allergy to other foods | Personal risk factors, not elsewhere classified (Z91) |
| Z91.02 | Food additives allergy status | Personal risk factors, not elsewhere classified (Z91) |
| Z91.030 | Bee allergy status | Personal risk factors, not elsewhere classified (Z91) |
| Z91.038 | Other insect allergy status | Personal risk factors, not elsewhere classified (Z91) |
| Z91.040 | Latex allergy status | Personal risk factors, not elsewhere classified (Z91) |
| Z91.041 | Radiographic dye allergy status | Personal risk factors, not elsewhere classified (Z91) |
| Z91.048 | Other nonmedicinal substance allergy status | Personal risk factors, not elsewhere classified (Z91) |
| Z91.09 | Other allergy status, other than to drugs and biological substances | Personal risk factors, not elsewhere classified (Z91) |
| Z91.11 | Patient's noncompliance with dietary regimen | Personal risk factors, not elsewhere classified (Z91) |
| Z91.120 | Patient's intentional underdosing of medication regimen due to financial hardship | Personal risk factors, not elsewhere classified (Z91) |
| Z91.128 | Patient's intentional underdosing of medication regimen for other reason | Personal risk factors, not elsewhere classified (Z91) |
| Z91.130 | Patient's unintentional underdosing of medication regimen due to age-related debility | Personal risk factors, not elsewhere classified (Z91) |
| Z91.138 | Patient's unintentional underdosing of medication regimen for other reason | Personal risk factors, not elsewhere classified (Z91) |
| Z91.14 | Patient's other noncompliance with medication regimen | Personal risk factors, not elsewhere classified (Z91) |
| Z91.15 | Patient's noncompliance with renal dialysis | Personal risk factors, not elsewhere classified (Z91) |
| Z91.19 | Patient's noncompliance with other medical treatment and regimen | Personal risk factors, not elsewhere classified (Z91) |
| Z91.410 | Personal history of adult physical and sexual abuse | Personal risk factors, not elsewhere classified (Z91) |
| Z91.411 | Personal history of adult psychological abuse | Personal risk factors, not elsewhere classified (Z91) |
| Z91.412 | Personal history of adult neglect | Personal risk factors, not elsewhere classified (Z91) |
| Z91.419 | Personal history of unspecified adult abuse | Personal risk factors, not elsewhere classified (Z91) |
| Z91.42 | Personal history of forced labor or sexual exploitation | Personal risk factors, not elsewhere classified (Z91) |
| Z91.49 | Other personal history of psychological trauma, not elsewhere classified | Personal risk factors, not elsewhere classified (Z91) |
| Z91.51 | Personal history of suicidal behavior | Personal risk factors, not elsewhere classified (Z91) |
| Z91.52 | Personal history of nonsuicidal self-harm | Personal risk factors, not elsewhere classified (Z91) |
| Z91.81 | History of falling | Personal risk factors, not elsewhere classified (Z91) |
| Z91.82 | Personal history of military deployment | Personal risk factors, not elsewhere classified (Z91) |
| Z91.841 | Risk for dental caries, low | Personal risk factors, not elsewhere classified (Z91) |
| Z91.842 | Risk for dental caries, moderate | Personal risk factors, not elsewhere classified (Z91) |
| Z91.843 | Risk for dental caries, high | Personal risk factors, not elsewhere classified (Z91) |
| Z91.849 | Unspecified risk for dental caries | Personal risk factors, not elsewhere classified (Z91) |
| Z91.89 | Other specified personal risk factors, not elsewhere classified | Personal risk factors, not elsewhere classified (Z91) |
| Z92.0 | Personal history of contraception | Personal history of medical treatment (Z92) |
| Z92.21 | Personal history of antineoplastic chemotherapy | Personal history of medical treatment (Z92) |
| Z92.22 | Personal history of monoclonal drug therapy | Personal history of medical treatment (Z92) |
| Z92.23 | Personal history of estrogen therapy | Personal history of medical treatment (Z92) |
| Z92.240 | Personal history of inhaled steroid therapy | Personal history of medical treatment (Z92) |
| Z92.241 | Personal history of systemic steroid therapy | Personal history of medical treatment (Z92) |
| Z92.25 | Personal history of immunosuppression therapy | Personal history of medical treatment (Z92) |
| Z92.29 | Personal history of other drug therapy | Personal history of medical treatment (Z92) |
| Z92.3 | Personal history of irradiation | Personal history of medical treatment (Z92) |
| Z92.81 | Personal history of extracorporeal membrane oxygenation (ECMO) | Personal history of medical treatment (Z92) |
| Z92.82 | Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility | Personal history of medical treatment (Z92) |
| Z92.83 | Personal history of failed moderate sedation | Personal history of medical treatment (Z92) |
| Z92.84 | Personal history of unintended awareness under general anesthesia | Personal history of medical treatment (Z92) |
| Z92.850 | Personal history of Chimeric Antigen Receptor T-cell therapy | Personal history of medical treatment (Z92) |
| Z92.858 | Personal history of other cellular therapy | Personal history of medical treatment (Z92) |
| Z92.859 | Personal history of cellular therapy, unspecified | Personal history of medical treatment (Z92) |
| Z92.86 | Personal history of gene therapy | Personal history of medical treatment (Z92) |
| Z92.89 | Personal history of other medical treatment | Personal history of medical treatment (Z92) |
| Z93.0 | Tracheostomy status | Artificial opening status (Z93) |
| Z93.1 | Gastrostomy status | Artificial opening status (Z93) |
| Z93.2 | Ileostomy status | Artificial opening status (Z93) |
| Z93.3 | Colostomy status | Artificial opening status (Z93) |
| Z93.4 | Other artificial openings of gastrointestinal tract status | Artificial opening status (Z93) |
| Z93.50 | Unspecified cystostomy status | Artificial opening status (Z93) |
| Z93.51 | Cutaneous-vesicostomy status | Artificial opening status (Z93) |
| Z93.52 | Appendico-vesicostomy status | Artificial opening status (Z93) |
| Z93.59 | Other cystostomy status | Artificial opening status (Z93) |
| Z93.6 | Other artificial openings of urinary tract status | Artificial opening status (Z93) |
| Z93.8 | Other artificial opening status | Artificial opening status (Z93) |
| Z93.9 | Artificial opening status, unspecified | Artificial opening status (Z93) |
| Z94.0 | Kidney transplant status | Transplanted organ and tissue status (Z94) |
| Z94.1 | Heart transplant status | Transplanted organ and tissue status (Z94) |
| Z94.2 | Lung transplant status | Transplanted organ and tissue status (Z94) |
| Z94.3 | Heart and lungs transplant status | Transplanted organ and tissue status (Z94) |
| Z94.4 | Liver transplant status | Transplanted organ and tissue status (Z94) |
| Z94.5 | Skin transplant status | Transplanted organ and tissue status (Z94) |
| Z94.6 | Bone transplant status | Transplanted organ and tissue status (Z94) |
| Z94.7 | Corneal transplant status | Transplanted organ and tissue status (Z94) |
| Z94.81 | Bone marrow transplant status | Transplanted organ and tissue status (Z94) |
| Z94.82 | Intestine transplant status | Transplanted organ and tissue status (Z94) |
| Z94.83 | Pancreas transplant status | Transplanted organ and tissue status (Z94) |
| Z94.84 | Stem cells transplant status | Transplanted organ and tissue status (Z94) |
| Z94.89 | Other transplanted organ and tissue status | Transplanted organ and tissue status (Z94) |
| Z94.9 | Transplanted organ and tissue status, unspecified | Transplanted organ and tissue status (Z94) |
| Z95.0 | Presence of cardiac pacemaker | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.1 | Presence of aortocoronary bypass graft | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.2 | Presence of prosthetic heart valve | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.3 | Presence of xenogenic heart valve | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.4 | Presence of other heart-valve replacement | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.5 | Presence of coronary angioplasty implant and graft | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.810 | Presence of automatic (implantable) cardiac defibrillator | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.811 | Presence of heart assist device | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.812 | Presence of fully implantable artificial heart | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.818 | Presence of other cardiac implants and grafts | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.820 | Peripheral vascular angioplasty status with implants and grafts | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.828 | Presence of other vascular implants and grafts | Presence of cardiac and vascular implants and grafts (Z95) |
| Z95.9 | Presence of cardiac and vascular implant and graft, unspecified | Presence of cardiac and vascular implants and grafts (Z95) |
| Z96.0 | Presence of urogenital implants | Presence of other functional implants (Z96) |
| Z96.1 | Presence of intraocular lens | Presence of other functional implants (Z96) |
| Z96.20 | Presence of otological and audiological implant, unspecified | Presence of other functional implants (Z96) |
| Z96.21 | Cochlear implant status | Presence of other functional implants (Z96) |
| Z96.22 | Myringotomy tube(s) status | Presence of other functional implants (Z96) |
| Z96.29 | Presence of other otological and audiological implants | Presence of other functional implants (Z96) |
| Z96.3 | Presence of artificial larynx | Presence of other functional implants (Z96) |
| Z96.41 | Presence of insulin pump (external) (internal) | Presence of other functional implants (Z96) |
| Z96.49 | Presence of other endocrine implants | Presence of other functional implants (Z96) |
| Z96.5 | Presence of tooth-root and mandibular implants | Presence of other functional implants (Z96) |
| Z96.60 | Presence of unspecified orthopedic joint implant | Presence of other functional implants (Z96) |
| Z96.611 | Presence of right artificial shoulder joint | Presence of other functional implants (Z96) |
| Z96.612 | Presence of left artificial shoulder joint | Presence of other functional implants (Z96) |
| Z96.619 | Presence of unspecified artificial shoulder joint | Presence of other functional implants (Z96) |
| Z96.621 | Presence of right artificial elbow joint | Presence of other functional implants (Z96) |
| Z96.622 | Presence of left artificial elbow joint | Presence of other functional implants (Z96) |
| Z96.629 | Presence of unspecified artificial elbow joint | Presence of other functional implants (Z96) |
| Z96.631 | Presence of right artificial wrist joint | Presence of other functional implants (Z96) |
| Z96.632 | Presence of left artificial wrist joint | Presence of other functional implants (Z96) |
| Z96.639 | Presence of unspecified artificial wrist joint | Presence of other functional implants (Z96) |
| Z96.641 | Presence of right artificial hip joint | Presence of other functional implants (Z96) |
| Z96.642 | Presence of left artificial hip joint | Presence of other functional implants (Z96) |
| Z96.643 | Presence of artificial hip joint, bilateral | Presence of other functional implants (Z96) |
| Z96.649 | Presence of unspecified artificial hip joint | Presence of other functional implants (Z96) |
| Z96.651 | Presence of right artificial knee joint | Presence of other functional implants (Z96) |
| Z96.652 | Presence of left artificial knee joint | Presence of other functional implants (Z96) |
| Z96.653 | Presence of artificial knee joint, bilateral | Presence of other functional implants (Z96) |
| Z96.659 | Presence of unspecified artificial knee joint | Presence of other functional implants (Z96) |
| Z96.661 | Presence of right artificial ankle joint | Presence of other functional implants (Z96) |
| Z96.662 | Presence of left artificial ankle joint | Presence of other functional implants (Z96) |
| Z96.669 | Presence of unspecified artificial ankle joint | Presence of other functional implants (Z96) |
| Z96.691 | Finger-joint replacement of right hand | Presence of other functional implants (Z96) |
| Z96.692 | Finger-joint replacement of left hand | Presence of other functional implants (Z96) |
| Z96.693 | Finger-joint replacement, bilateral | Presence of other functional implants (Z96) |
| Z96.698 | Presence of other orthopedic joint implants | Presence of other functional implants (Z96) |
| Z96.7 | Presence of other bone and tendon implants | Presence of other functional implants (Z96) |
| Z96.81 | Presence of artificial skin | Presence of other functional implants (Z96) |
| Z96.82 | Presence of neurostimulator | Presence of other functional implants (Z96) |
| Z96.89 | Presence of other specified functional implants | Presence of other functional implants (Z96) |
| Z96.9 | Presence of functional implant, unspecified | Presence of other functional implants (Z96) |
| Z97.0 | Presence of artificial eye | Presence of other devices (Z97) |
| Z97.10 | Presence of artificial limb (complete) (partial), unspecified | Presence of other devices (Z97) |
| Z97.11 | Presence of artificial right arm (complete) (partial) | Presence of other devices (Z97) |
| Z97.12 | Presence of artificial left arm (complete) (partial) | Presence of other devices (Z97) |
| Z97.13 | Presence of artificial right leg (complete) (partial) | Presence of other devices (Z97) |
| Z97.14 | Presence of artificial left leg (complete) (partial) | Presence of other devices (Z97) |
| Z97.15 | Presence of artificial arms, bilateral (complete) (partial) | Presence of other devices (Z97) |
| Z97.16 | Presence of artificial legs, bilateral (complete) (partial) | Presence of other devices (Z97) |
| Z97.2 | Presence of dental prosthetic device (complete) (partial) | Presence of other devices (Z97) |
| Z97.3 | Presence of spectacles and contact lenses | Presence of other devices (Z97) |
| Z97.4 | Presence of external hearing-aid | Presence of other devices (Z97) |
| Z97.5 | Presence of (intrauterine) contraceptive device | Presence of other devices (Z97) |
| Z97.8 | Presence of other specified devices | Presence of other devices (Z97) |
| Z98.0 | Intestinal bypass and anastomosis status | Other postprocedural states (Z98) |
| Z98.1 | Arthrodesis status | Other postprocedural states (Z98) |
| Z98.2 | Presence of cerebrospinal fluid drainage device | Other postprocedural states (Z98) |
| Z98.3 | Post therapeutic collapse of lung status | Other postprocedural states (Z98) |
| Z98.41 | Cataract extraction status, right eye | Other postprocedural states (Z98) |
| Z98.42 | Cataract extraction status, left eye | Other postprocedural states (Z98) |
| Z98.49 | Cataract extraction status, unspecified eye | Other postprocedural states (Z98) |
| Z98.51 | Tubal ligation status | Other postprocedural states (Z98) |
| Z98.52 | Vasectomy status | Other postprocedural states (Z98) |
| Z98.61 | Coronary angioplasty status | Other postprocedural states (Z98) |
| Z98.62 | Peripheral vascular angioplasty status | Other postprocedural states (Z98) |
| Z98.810 | Dental sealant status | Other postprocedural states (Z98) |
| Z98.811 | Dental restoration status | Other postprocedural states (Z98) |
| Z98.818 | Other dental procedure status | Other postprocedural states (Z98) |
| Z98.82 | Breast implant status | Other postprocedural states (Z98) |
| Z98.83 | Filtering (vitreous) bleb after glaucoma surgery status | Other postprocedural states (Z98) |
| Z98.84 | Bariatric surgery status | Other postprocedural states (Z98) |
| Z98.85 | Transplanted organ removal status | Other postprocedural states (Z98) |
| Z98.86 | Personal history of breast implant removal | Other postprocedural states (Z98) |
| Z98.870 | Personal history of in utero procedure during pregnancy | Other postprocedural states (Z98) |
| Z98.871 | Personal history of in utero procedure while a fetus | Other postprocedural states (Z98) |
| Z98.890 | Other specified postprocedural states | Other postprocedural states (Z98) |
| Z98.891 | History of uterine scar from previous surgery | Other postprocedural states (Z98) |
| Z99.0 | Dependence on aspirator | Dependence on enabling machines and devices, NEC (Z99) |
| Z99.2 | Dependence on renal dialysis | Dependence on enabling machines and devices, NEC (Z99) |
| Z99.3 | Dependence on wheelchair | Dependence on enabling machines and devices, NEC (Z99) |
| Z99.81 | Dependence on supplemental oxygen | Dependence on enabling machines and devices, NEC (Z99) |
| Z99.89 | Dependence on other enabling machines and devices | Dependence on enabling machines and devices, NEC (Z99) |